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Summary 
This doctorate thesis focuses on shortcomings in neurochemical investigations in 
human pain research by means of proton magnetic resonance spectroscopy (1H-
MRS). The first study (reproducibility study) explored the frequent issue of 
insufficient anatomical/functional specificity in 1H-MRS investigations. We 
investigated the measurability of small substructures of the cingulate and insular 
cortex with adequate specificity by means of anatomically adapted measuring 
voxels and found that good data quality and high reproducibility are achievable 
despite strongly reduced voxel sizes. In the second study, we strived to make 
structures of the human brainstem accessible to functional 1H-MRS 
investigations for the first time. We sought to enable the characterization of 
neurochemical dynamics in brainstem nuclei involved in pain processing by 
means of optimized 1H-MRS-techniques. The results revealed reduced 
concentrations in the total N-acetylaspartate and GABA signal during orofacial 
stimulation in the trigeminal nuclear complex.   
The third study deviates from the focus on 1H-MRS, but it adds a valuable 
dimension to this doctoral thesis. In this work, the pain-specificity of pain-
associated areas was investigated by means of fMRI using a nerve block to clearly 
differentiate painful from non-pain perceptions without changing physical 
stimulus. The main results indicate towards a pain-specificity of the posterior 
component of the insula and the parietal operculum.  
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Zusammenfassung 
Diese Dissertation befasst sich mit Limitierungen der 
Magnetresonanzspektroskopie in der humanen Schmerzforschung. Die erste 
Studie untersuchte das verbreitete Problem der unzureichenden anatomisch-
funktionellen Spezifität in 1H-MRS Studien. Wir untersuchten die Messbarkeit 
kleiner Substrukturen des Cingulums und insulären Kortex mit adäquater 
Spezifität mittels an die Anatomie angepasster Messvoxel und fanden heraus, 
dass gute Datenqualität und hohe Reproduzierbarkeit erreichbar sind trotz stark 
reduzierter Voxelgrössen. In der zweiten Studie machten wir Strukturen des 
menschlichen Hirnstamms erstmals für funktionelle 1H-MRS-Untersuchungen 
zugänglich. Wir ermöglichten die Charakterisierung neurochemischer Dynamiken 
in schmerzverarbeitenden Hirnstammkernen mittels optimierter 1H-MRS-
Techniken. Die Ergebnisse zeigten reduzierte Konzentrationen im gesamten N-
Acetylaspartat- und GABA-Signal während orofazialer Stimulation im 
trigeminalen Kernkomplex.   
Die dritte Studie weicht vom Fokus auf 1H-MRS ab, fügt aber dieser Dissertation 
eine wertvolle Dimension hinzu. In dieser Arbeit wurde die Schmerzspezifität von 
schmerzassoziierten Hirnregionen mittels fMRI mit Hilfe einer Nervenblockade 
untersucht, um schmerzhafte von nicht-schmerzhaften Wahrnehmungen ohne 
Veränderung des Schmerzstimulus klar zu unterscheiden. Die Hauptergebnisse 
deuten auf eine Schmerzspezifität des posterioren Anteils der Insula und des 
parietalen Operculums hin.  
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Preface 
uring a journey we often deviate from a planned route, sometimes 
because of encountered obstacles or because we decide to listen to 
our gut feeling, guiding us to new places, which were unimaginable 
beforehand. The original plan for my PhD-thesis was the continuation of the 
proton magnetic resonance spectroscopy (1H-MRS) studies conducted by our 
group (Gutzeit et al., 2011; Gutzeit et al., 2013). These two studies were part of 
an emerging field in pain research, which sought out to uncover the 
neurochemical underpinnings of acute pain processing. In these studies, 
significant multiple neurochemical pain-related alterations in the insular cortices 
were identified. 
At the start of my work, I aimed at providing a valuable contribution to this new 
field of neuroscientific research by applying the same experimental paradigm to 
other brain structures in order to start an extensive mapping of pain-related 
neurochemical processes across regions of the pain-processing network.  
However, while my technical understanding about 1H-MRS deepened, I became 
increasingly aware of significant shortcomings in commonly used functional 1H-
MRS-paradigms in the field of human pain research. As a consequence, I saw 
myself at a crossroad with two possible directions: On the one hand, I could 
follow the direction intended by my original plan; a probably more comfortable 
and quicker road although with the bad aftertaste of being subject to the same 
methodical shortcomings common in the field. On the other hand, I could decide 
for an unknown, possibly longer and bumpier road, although with the prospect 
of a more satisfactory destination.  
So we decided to follow the bumpy path by changing the emphasis of my PhD 
more towards the methodical aspects of 1H-MRS and addressed frequent 
methodical issues of 1H-MRS in the field of pain research (and research in 
general). This project became a highly interdisciplinary endeavor, demanding a 
D 
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close relationship between the Center of Dental Medicine, University of Zurich 
and 1H-MRS-specialists from the Institute of Biomedical Engineering of the Swiss 
Federal Institute of Technology in order to successfully tackle the 
aforementioned issues.  
Needless to say, this new path took us much longer to walk than expected. The 
financial resources we received for the original plan were enough to cover my 
employment as a PhD student at the Center for Dental Medicine for two years, 
which was not nearly sufficient. Solving the technical challenges was highly time-
consuming. After the two years, we were unsuccessful in acquiring new funding. 
Fortunately I had the chance to take a part-time research position at the Institute 
for Complementary and Integrative Medicine of the University Hospital Zurich. 
This position allowed me to obtain new valuable scientific skills, but it also 
strongly limited my available time to work on the PhD-projects which further 
delayed their completion. 
Four and a half years after the inception of my doctorate program, the journey 
was at the end. This thesis is not only the result of sustained and sizable efforts 
from my mentor Dr. Mike Brügger and the highly committed multidisciplinary 
group of scientists who accompanied me along this path. Equally important were 
the test participants who agreed to let themselves suffer pain for the sake of 
science. I had the first contact with this kind of research in the year 2006 as a 
participant in Dr. Mike Brügger’s first study. I started as a test subject attracted 
by the payment but continued to participate again and again due to my growing 
scientific interest in and fascination for the topic. I believe that my extensive 
experience as a volunteer in a multitude of pain studies (and studies in general) 
helped me in bringing a level of sensitivity and empathy towards the subjects 
participating in our experiments. Besides of all the technical and methodical 
aspects of a well-conducted 1H-MRS pain research I had learned during my 
studies, I realized that the development of an empathic and comforting approach 
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to the test subjects is of equal importance. Keeping the volunteers calm and 
giving them the sense of “control” over the situation is at least as important as 
the cleanliness of the scientific/methodical approach.  
This journey — despite (and maybe because of) the sometimes rough sections, 
its long distance and sharp turns — led me to a place of contentment and pride 
for the accomplished work. The awareness of the methodical pitfalls and the 
knowledge how to prevent/ameliorate them gives me confidence in the 
potential of 1H-MRS-method in providing essential insights into the processing of 
acute pain and the formation of chronic pain in particular. 
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1 Introduction 
Our relationship to the conscious experience called pain is a complex one. It has 
been our friend for millions of years, fostering our survival as a species by 
teaching us how to avoid things that endanger us. It tells us if and what part of 
the body needs rest in order to promote its healing. And: Pain is highly 
subjective. Each person perceives pain in their unique way, depending on their 
(epi-)genetic constitution but also on brain-based processes such as mood, 
perceived stress level, episodic memories, psychological traits, interpretation of 
environmental situations, just to name a few (Tracey and Mantyh, 2007; Denk et 
al., 2014).  
Thus, the experience of pain is not a simple unidirectional propagation of 
nociceptive signals from the body through the peripheral (PNS) to the central 
nervous system (CNS) as suggested by René Descartes in the 16th century and still 
adopted by many. Modern views tell a different story, one of highly dynamic 
processes in complex brain networks which produce the qualia called pain.  
The question how the multifaceted pain experience emerges in the nervous 
system from simple nociceptive signals has been the subject of a plethora of 
neuroscientific studies. Since the advent of neuroimaging techniques, our 
understanding has grown tremendously about the brain networks involved in the 
processing of acute pain. We also gained new insights about how the 
communication patterns between pain processing areas could explain dynamic 
aspects of pain perception. And, we are also starting to understand which brain 
processes contribute to chronic pain. Chapter 2 provides an overview and 
describes these findings in more detail.  
The catalyst of this neuroimaging revolution in the field of human pain research 
is probably the functional magnetic resonance imaging technique (fMRI). 
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Since its inception in the early 90’s by Seiji Ogawa (Ogawa et al., 1990), this 
method has granted noninvasive access to the brain activity of living human 
beings, allowing researchers to observe how brain activity patterns correlate 
with pain perception. Although other methods, such as electroencephalography 
(EEG), magnetoencephalography (MEG) and positron emission tomography (PET) 
have also contributed significantly to our current understanding, the fMRI-
technique may have played the biggest role due to the availability of MR-
scanners and its relatively high spatial and temporal resolution (Figure 1).  
However, despite the important contribution provided by fMRI, it lacks a certain 
“depth”. This technique is based on the indirect observation of relative changes 
in blood perfusion through quantification of the blood-oxygen-level dependent 
(BOLD) contrast (Logothetis et al., 2001). This contrast works by the 
quantification of changes in the T2* decay in a given voxel as a consequence of 
alterations in the ratio of oxyhemoglobin (oxyHb) to deoxyhemoglobin (deoxyHb) 
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Figure 1: Illustration of the yearly publication frequency of pain studies using one of four 
different neuroimaging techniques: EEG, PET, 
1
H-MRS and fMRI. Data is based on Pubmed 
searches (February 2019) using the designation of the methods as keyword in combination 
with the keyword “pain”. 
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due to a process called hemodynamic response (D'Esposito et al., 2003). In this 
process, increases in neuronal and glial activity, such as neurotransmission, 
modulate the level of vasodilatation and vasoconstriction, resulting in a local 
overcompensation of oxygenated blood thus increasing the ratio of oxyHb to 
deoxyHb (Lauritzen et al., 2012). Due to the diamagnetic nature of oxyHb, the 
overcompensation with fresh blood leads to longer T2* relaxation times, finally 
causing an increase in the fMRI-signal (D'Esposito et al., 2003).  
Yet, until this day, the link between neurotransmittory systems and BOLD-
dynamics are still not fully understood (Logothetis, 2008; Lauritzen et al., 2012). 
Research suggests that the activation of both excitatory and inhibitory neurons 
increase the cerebral blood flow and hence the BOLD signal (Logothetis, 2008). In 
contrast, decreases in BOLD-signals have mainly been linked to the activity of 
inhibitory interneurons, although exceptions exist (Lauritzen et al., 2012). To sum 
up, based on the BOLD signals alone, it is not possible to deduce the excitatory 
and inhibitory processes (Lauritzen et al., 2012). 
A less common MR-based technique is the proton magnetic resonance 
spectroscopy (1H-MRS). In contrast to fMRI, 1H-MRS is capable of providing direct 
concentration estimates of multiple neurochemicals in a pre-defined part of the 
brain in a non-invasive fashion. In that sense, this method can be regarded as a 
kind of virtual tissue biopsy, granting simultaneous information about the 
underlying energy metabolism, myelination and membrane metabolism, 
neurotransmitter status, antioxidant and osmolyte concentration levels, just 
using a standard MR scanner (Graaf, 2007; Stagg, 2013).  
The application of 1H-MRS to pain research has promising potential by providing 
novel insights, also through its combination with other neuroimaging techniques 
such as fMRI. However, 1H-MRS is still mainly a clinical tool for the identification 
of tumors and other pathological tissue conditions. Many applied 1H-MRS-
sequences are not optimized for specific neuroscientific investigations like pain 
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research due to the large measurement volumes used and static nature of the 
examinations.  
In this doctorate thesis I have started at this point. During the examination of 
available literature on the dynamic neurochemical processes of pain processing 
in distinct brain regions using  1H-MRS, we realized that the applied 1H-MRS 
procedures were often suboptimal hence limiting its vast potential in pain 
research.  
We addressed frequent methodical limitations common in experimental 1H-MRS 
investigations. Therefore, the first study of my thesis tackled the issue of the lack 
of anatomical/functional specificity. In the context of a reproducibility study, 
neurochemical profiles were measured using common 1H-MRS sequences and 
MR-equipment in order to enable a generalization to most clinical and scientific 
settings. For this purpose, four cortical regions prominent in pain processing 
were measured with optimized structural and functional specificity. The 
measurements were repeated at four different days in order to evaluate the 
impact of the reduced voxel dimensions on spectral quality and associated 
reproducibility metrics. In addition, the systematic effects of participant 
movement, tissue composition in the measurement volume and time of day on 
neurochemical quantification were explored in order to obtain valuable 
knowledge for the planning of future (pain) studies using 1H-MRS.   
In the second study, we strived to open a new door for the field of pain research: 
To make structures of the human brainstem accessible to functional 1H-MRS 
investigations for the first time. We sought to enable the characterization of 
neurochemical dynamics in brainstem nuclei involved in the processing of 
nociceptive signals. In order to achieve this goal, 1H-MRS-techniques from spinal 
cord research were optimized for neurochemical quantifications in the brainstem 
(Hock et al., 2016; Wyss et al., 2017). In addition, we also addressed issues of 
systematic quantification errors common in functional 1H-MRS studies which 
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may mimic real neurochemical effects. The presented approaches add to the 
validity of 1H-MRS in experimental settings.  
In the third study I had a contributing role as a co-author. Although this study 
deviates from the focus on 1H-MRS, it adds a valuable dimension to this doctoral 
thesis. In this work, an innovative experimental approach was used to clearly 
differentiate painful from non-pain perceptions without changing physical 
stimulus strengths as perceptions were modulated by means of lidocaine 
injections. 
Before the presentation of these three studies, several chapters are presented in 
order to provide a foundation to readers unfamiliar with this field in order to 
foster a basic understanding for some of the rationales of the study 1-3 and the 
proposed ideas for future research. 
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2 1H-MRS: A Methodical Overview 
Its uniqueness compared to other MR-based methods is that 1H-MRS focuses on 
specific resonance frequencies attributable to single substances (Stagg, 2013). As 
all magnetic resonance-based techniques, its signals are governed by the larmor 
equation. 
       0 
 
The larmor frequency ω defines the frequency of signals obtained by MR 
techniques and describes the precession frequency of proton nuclei when they 
become polarized, either parallel or antiparallel to an external magnetic field B0 
(B0 corresponds to a static magnetic field of a scanner, typically 1.5, 3 or 7 Tesla) 
(Graaf, 2007). In addition to B0, ω depends on the gyromagnetic ratio γ which is a 
nucleus-specific constant. Now, if B0 is the only factor influencing ω, how are 
different substances identifiable simply based on the larmor frequency? 
2.1.1 Differentiation of Neurochemical Compounds Based on Chemical Shift 
and Scalar Coupling 
The answer is that the larmor frequency of proton nuclei is also affected by their 
chemical environment. This phenomenon is caused by shielding (or screening) of 
proton nuclei from the B0 field by the magnetic fields generated by surrounding 
electrons (Figure 2) (Graaf, 2007; Stagg, 2013). This effect is called chemical shift 
and constitutes the basic concept of 1H-MRS. As a consequence of this 
mechanism, neurochemicals in a 1H-MRS-spectrum are typically represented 
over a frequency range. This frequency range is usually not reported in Hertz, but 
rather in parts per million, or PPM. The advantage of the use of PPM is the 
independence of the chemical shift from the underlying magnetic field strength,  
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allowing the comparison of spectra from different MR scanners working at 1.5, 3, 
7 Tesla etc. Therefore, chemical shifts are usually defined as follows:  
 
   
      
    
      
 
Figure 2: Chemical shift phenomenon. A) The electrons surrounding a proton nucleus can be 
imagined as currents due to their charge, creating a magnetic moment μe. As μe is oppositely 
oriented to the magnetic moment of the nucleus polarized to B0, the effective magnetic field 
affecting the nucleus is reduced, resulting in an altered larmor frequency. B) The strength of the 
electronic shielding also depends on the characteristics of the electron bonds. In this example, 
the electronegative oxygen exerts a pull on the electron, leading to a reduced electronic 
shielding at the methine (-CH) protons. As a consequence, the resulting reduction in the larmor 
frequency is less pronounced compared to other protons C) The different larmor frequencies of 
the methine (-CH) and methyl (-CH3) protons due to the electronegative oxygen is sufficient to 
explain the basic configuration of the MR spectrum of the substance lactate (From De Graaf 
(2007, modified by the author).  
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 where   refers to the frequencies of the neurochemical-of-interest and      
refers to the reference molecule, usually tetramethylsilane (TMS), to which 
    has been assigned (Graaf, 2007). Neurochemicals measured using 1H-MRS 
are usually represented over a ppm-range of 0-4. 
As illustrated, the chemical shift phenomenon provides direct information about 
the chemical environment of nuclei, thereby enabling the detection of 
neurochemicals. Furthermore, as the signal originates directly from the nuclei in 
a specific neurochemical, the area of the spectrum is proportional its 
concentration, thus making 1H-MRS a quantitative method (Stagg, 2013).  
Spectral resonances are usually not just represented by a single frequency peak, 
but are present as characteristic multiplet structures with various peaks. The 
mechanism causing the splitting of frequencies into multiplet structures is called 
scalar coupling or J coupling, or spin-spin coupling (Graaf, 2007). This additional 
feature is caused by interactions between nuclei with magnetic moments, either 
directly through space (dipole coupling) or through electrons in the bonds (scalar 
coupling) (Graaf, 2007). Here I shall provide a strongly simplified example in 
order to illustrate this process. For a system with two nuclei with a spin, four 
different spin configurations are possible depending on the parallel and 
antiparallel spin orientation of nuclei and electrons. The possible energy level 
transitions give rise to additional resonance frequencies for each nucleus, thus 
creating additional peaks for each nucleus. Depending on the energetic levels of 
each configuration, some may occur more often than others, resulting in possible 
different peak heights in the multiplet structure. Scalar couplings are constants 
as they are solely based on the fundamental principle of spin-spin pairing and are 
thus independent of the external magnetic field (Graaf, 2007).  
Hence, the phenomena of chemical shift together with scalar coupling contribute 
to the individual and distinguishable spectral pattern of a given neurochemical.  
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However, depending on the external magnetic field, chemical shift and scalar 
coupling differ in their contribution to the discriminability of distinct 
neurochemicals. For example, increases in B0 may be beneficial for the 
neurochemical discrimination due to higher chemical shift dispersions (leading to 
bigger distances between the substances represented on the ppm-axis), but the 
multiplet structures become less apparent as the multiplet peaks are shifted 
toward each other from a relativistic point of view. At 3T, multiplet structures 
are more prominent, allowing their utilization for the identification of substances 
with strongly overlapping chemical shifts. 
 
2.1.2 Water vs. Neurochemicals 
Water is by far the most abundant substance in the brain, with water spectra 
amplitudes more than three orders of magnitude larger compared to the spectra 
of neurochemicals (Figure 3)(Stagg, 2013). As a consequence, the removal of 
water peaks either by suppression or spectral subtracting methods is essential in 
order to reveal the neurochemical signals.  
The sizeable difference between water and neurochemical signals is the reason 
for the modest spatial and temporal resolution of 1H-MRS compared to other 
imaging techniques. fMRI utilizes mostly the large signal generated by water, 
providing it the necessary signal-to-noise ratio (SNR)  for whole-head acquisitions 
with millimeter voxel dimensions in seconds. Due to the comparably small signal 
obtained by 1H-MRS, large voxel sizes are needed (typically 8 cm3 in single voxel 
protocols) to compensate for the small signals and many acquisitions (typically  
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128) must be averaged in order to remove substantial noise from the data. As a 
result, the measurement of a neurochemical spectrum typically requires minutes 
in order to provide single concentration estimates. The acquisition time strongly 
depends on other parameters such as the strength of the static magnetic field, 
voxel size, applied localization techniques and MR-hardware used .  
2.1.3 Localization of 1H-MRS-Signals 
For neuroscientific investigations, single-voxel techniques are frequently used for 
the derivation of neurochemical information from a specific region, including the 
empirical 1H-MRS studies conducted in this thesis. The usage of a single voxel 1H-
MRS (SV-MRS) compared to 1H-MRS-imaging (MRSI) brings some advantages, like 
improved data quality due to better shimming and thus improved B0  
Figure 3: Illustration of the minute proportion of neurochemical signal compared to the water 
signal usually acquired with 
1
H-MRS. A) The water signal is approximately 5000 times higher 
than the signal from the neurochemicals. In order to process neurochemical spectra, the water 
peak is usually suppressed, B) revealing the spectrum containing neurochemical information. 
(From Stagg & Rothmann, 2013) 
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homogeneity. And theoretically, the capability of adapting voxel sizes and 
orientation to the structural shape of a region-of-interest (ROI) is an advantage 
for measurements aiming for optimal anatomical and functional homogeneity.  
The main localization method at 3 Tesla is the gradient-based Point Resolved 
Spectroscopy (PRESS). Both 1H-MRS studies conducted in this thesis used PRESS, 
whereas the study focusing on the brainstem applied a novel variant of the 
PRESS sequence called Metabolite Cycling PRESS (MC-PRESS). The localization 
procedure is the same; the MC-PRESS variant differs due its preservation of the 
water peak.  
PRESS sequences usually apply three slice-selective RF-pulses: A 90° and two 
180° RF-pulses with a specific echo time (TE) defining the time between RF-
pulses. The first RF pulse flips protons from the longitudinal axis to the 
transverse plane in the first slice. The following 180° pulses consecutively refocus 
the magnetization, resulting in spin echoes originating from a voxel defined by 
the intersection of all three RF-pulses (Stagg, 2013) (Figure 4). The PRESS 
Figure 4: Depiction of gradient-based localization technique for SV-MRS such as PRESS and MC-
PRESS. This method combines three slice-selective RF-pulses. With each pulse, an additional 
selective dimension is added, in the end resulting in a voxel providing the spectral information. 
(From Stagg & Rothmann, 2013, modified by the author) 
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sequences are usually combined with water suppressing pulses such as VAPOR 
(Variable Pulse power and Optimized Relaxation delays), or in the case of MC-
PRESS, up- and downfield pulses result in upward and downward oriented water 
peaks, which cancel themselves out during averaging, enabling the 
neurochemical quantification (Dreher and Leibfritz, 2005). The advantage of MC-
PRESS is, the water peak of each acquisition is preserved and can be used for 
frequency alignment, phase and eddy current correction before averaging of 
neurochemical spectra. Hence, MC-PRESS enables the reduction of frequency 
shifts caused by pulsatile effects of blood vessels/CSF and B0 drifts, making it 
suitable for regions subject to high levels of pulsation such as brainstem 
structures.  
The TE strongly influences the obtainable neurochemical information. As 
complex multiplet structures such as neurotransmitters decay quicker, short TE 
are needed in order to obtain the most signal possible from substances such as 
glutamate (Glu), Glutamine (Gln) or GABA. Therefore, neuroscientific 
investigations usually apply TEs of 30-40 ms. In contrast, clinical investigations 
usually use TEs > 100 ms in order to reduce the baseline distortions due to 
macromolecules and lipids, but at the cost of a loss of the signal of 
neurotransmitter systems.  
One of the drawbacks of all localization methods, including PRESS, is the 
chemical shift displacement artifact (CSD) (Stagg, 2013). Although the physical 
effects of chemical shift and scalar coupling are the basis for all MRS techniques, 
they also have associated issues that need to be recognized in order to provide 
meaningful results. As described above, magnetic field gradients are applied to 
define the spatial characteristics of the RF-pulses. But as described in 1.2.1, 
different compounds have different larmor frequencies and are therefore 
excited at slightly shifted voxel locations (Kreis, 2004; Stagg, 2013). The direction 
of the shift depends on the excitation orientation of the first 90° RF-pulse from  
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the PRESS sequence. In essence, this means that each neurochemical has its own 
voxel, each shifted to each other depending on their chemical shift properties. In 
order to minimize CSD, the voxel sizes can be reduced (as the chemical shift 
displacement is proportional to the voxel dimensions) or outer-volume 
suppression bands can be applied in order to create a voxel containing signals 
from all neurochemicals-of-interest (Figure 5). 
2.1.4 Spectral Quality: Spectral Resolution and Signal-to-Noise Ratio 
The signal used in 1H-MRS provided by PRESS sequences is usually the free 
induction decay (FID) of the second spin-echo. The T2-decay of the spin-echo 
contains the different larmor frequency contributions originating from the 
underlying compounds. The decay-signal is transformed from the time to the  
 
Figure 5: Depiction of a measurement voxel planning of a MC-PRESS sequence in the human 
periaqueductal gray superimposed on a sagittal T1-weghted MPRAGE image. Chemical shift 
displacement artifact is illustrated by the red and orange box. The orange box represents the 
voxel providing the signal of creatine, the red box represents the relatively displaced voxel of 
lactate (unpublished data from own ongoing research).  
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frequency domain by means of a fast fourier transformation (FFT), revealing the 
different frequency components in the signal. Spectral quality is directly 
connected to the T2-decay pattern (Figure 6): The longer the decay, the better 
the linewidth (LW) of the peaks in the frequency domain. LW is usually reported 
as full-width-at-half-maximum (FWHM) and represents the width of the peak at 
its half height. LW is reported in Hertz.  
The spectral noise level is reported as signal-to-noise ratio (SNR) and is usually 
calculated as ratio of the peak amplitude to the standard deviation of the noise 
(Kreis, 2004). From figure 6 it is evident, that with narrower LW the SNR also 
Figure 6: Link between spectral characteristics in the frequency domain (right) compared to the 
characteristics of the FID. In the left panel, three FIDs are depicted with different levels of signal 
damping, imitating different signal decay rates. In all three FIDs, the noise (N) is kept constant at 
a signal-to-noise (SNR) rate of 10. In the right panel, the corresponding data in the frequency 
domain is presented. Firstly, it is evident that the slower the decay, the better the spectral 
resolution (indicated by the linewidth using full width at half maximum (FWHM) estimates). 
Secondly, although the SNR in the time domain remains the same, it differs significantly in the 
frequency domain due to a reduction in signal intensity (I) with shorter decays. (From Kreis, 
2004) 
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improves. LW and SNR are the most important determinants of spectral quality. 
Narrow LWs are crucial for the resolution of small multiplet structures such as 
neurotransmitters. SNR is also important as it needs to be low in order to unveil 
the small multiplet structures of interest.  
As mentioned in section 2.1.2, in comparison to other imaging methods, 1H-MRS 
suffers inherently from low signal levels. In order to compensate for small levels 
of signals, usually large voxel dimensions are applied, typically 8 cm3. The 
problem is that with large voxels, the shimming of the B0 in the voxel becomes 
less efficient, leading to larger field heterogeneity. As a consequence, the FID-
decay shortens, resulting in worse spectral resolution. The aim of the 
reproducibility study conducted in the frame of this thesis questions this 
approach: As small voxels are easier to shim, the spectral resolution should 
improve. And as improved peak linewidths result in improved signal-to-noise 
ratios, SNR reductions should be compensated by the increased peak amplitudes 
up to a certain degree. Thus, a reduction in voxel sizes might be acceptable in 
order to improve anatomical and functional homogeneity. 
2.1.5 Quantification of MR Spectra and Related Quality Measures 
The most common software applied for the quantification of in-vivo MR spectra 
is LCModel (Provencher, 1993; Provencher, 2001). This software uses a linear 
combination of basis spectra (also named model spectra, hence the name 
LCModel) of all neurochemicals included in the analysis and fits them together 
on the raw spectrum in order to identify the contribution of each included 
neurochemical to the fitted spectrum.  
A good fit between the fitted and raw data is indicated by the residual as evenly 
distributed noise around 0 (see Figure 7). LCModel provides LW and SNR 
estimates for the largest peak in the spectrum, usually N-acetylaspartate (NAA, 
large peak at 2.0 ppm) for spectral quality control.  
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Another useful quality measure provided by LCModel are the fitting-error 
estimates calculated as Cramer-Rao lower bounds (CRLBs). CRLBs represent the 
stochastic uncertainty for a single measurement as lower bounds for the 
variance (Kreis, 2004). This metric considers inherent limits of fitting with a 
model, together with estimates of the interdependence of fitting parameters, 
effects of prior knowledge constraints and spectral quality measures such as LW 
and SNR for its variance estimates (Kreis, 2004).    
Figure 7: Exemplary LCModel output from a 2.4 cm
3
 voxel recorded in the posterior insular cortex 
(TE = 32ms, TR = 2500ms, 384 acquisitions) at 3T from a healthy male volunteer (data from own 
unpublished research). The main area of the output shows the fitted spectrum consisting of the 
linear combination of basis spectra (red line) over-imposed on the eddy current and phase-
corrected raw data. The line under the fit represents the baseline. The residual (Raw-Fit) is 
displayed above the spectrum. On the right, absolute concentration estimates, concentration 
ratios (concentrations relative to Creatine) and fitting errors (Cramer-Rao lower bounds as %SD) 
are provided. In addition, peaks are labeled to provide a sense for the main contributing 
neurochemicals. 
Residual 
Raw 
Fit 
Baseline 
NAA 
GABA Lactate 
Glutamate/
Glutamine 
Creatine 
Myo-
Inositol 
NAA 
Choline 
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There is a debate going on about which CRLB values are considered reliable for a 
quantification estimate. The common opinion shared by many 
researchers/experts is that a CRLB < 20% is regarded as reliable (Stagg, 2013). 
From my point of view, the focus on a simple value could be too conservative 
and should depend on other aspects like the expected effect sizes and study 
sample. As mentioned before, CRLBs represent a stochastic uncertainty assuming 
the model is correct. As such, the quantification error is normally distributed 
around the “true” concentration value. The higher the CRLBs, the broader the 
distribution of the concentration estimates, resulting in a reduced sensitivity of 
the method to detect signal changes. Following this rationale, the higher the 
CRLBs, the larger sample size is needed in order to reduce the variance.  
As CRLBs consider both, LW and SNR, it is a more accurate measure to judge the 
quantified data compared to statements of SNR and LW alone (Kreis, 2004). 
However, for quality control it is beneficial to set quality thresholds. For 
example, in the TBSNC-study, we applied a threshold of 0.070 ppm for the LW of 
the NAA-peak as recommended by Kreis (2004). In addition, we chose a SNR-
threshold of 10. Both thresholds were chosen in order to allow for sufficient data 
quality for an improved quantification of GABA. 
 
3 Neural Correlates of Pain  
3.1 From Pure Nociception to a Multifaceted Pain Experience 
3.1.1 Formation and Propagation of Nociceptive Signals 
Under normal circumstances, the sensation of pain starts with the detection of 
(potentially) noxious stimuli or inflammation by the PNS. The underlying 
mechanisms are summarized in figure 1. In this process called nociception, 
receptors and ion channels located at the endings of myelinated A-δ and  
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Figure 18: Illustration of nociceptive, inflammatory and neuropathic pain mechanisms. a) 
Nociceptive pain: Noxious stimuli affecting the body are detected via receptors located at the 
nerve endings, which are transduced to electrical signals and propagated to the dorsal horn of 
the spinal cord. There the nociceptive signal induce withdrawal reflexes via interneuron 
circuits or are relayed to pain-processing structures. b) Inflammatory pain is caused by 
chemical mediators released as a consequence of tissue damage, inflammation or released by 
cancer tissue. Chemical mediators act on the nerve endings, thus modulating nerve fiber 
responses. c) Neuropathic pain originates as a consequence of lesions or dysfunction of the 
nervous system. (Figure from Scholz and Woolf, 2002 modified by the author) 
 
 28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
unmyelinated C nerve fibers translate various modalities of noxious stimuli (such 
as heat, cold, mechanical forces and acid) into electrical currents which are 
relayed to the CNS via 1st-order synapses (Scholz and Woolf, 2002). Inflammatory 
pain resulting from tissue damage and inflammation functions via the 
modulation of the same nerve endings through the release of an “inflammatory 
soup” consisting of a multitude of chemical mediators promoting peripheral 
sensitization (Scholz and Woolf, 2002). Noxious and inflammatory stimuli from 
the body synapse in the dorsal horn of the spinal cord (figure 8). In contrast, 
stimuli originating from the craniofacial areas are mainly propagated via the 
trigeminal nerve and enter the brain at the level of the pons and synapse in 
nuclei of the trigeminal brainstem sensory nuclear complex, (TBSNC) (Sessle, 
2000; DaSilva and DosSantos, 2012)(see figure 9).  
Figure 9: Schematic depiction of 
the craniofacial nociceptive signal 
cascade. Noxious and 
inflammatory signals from the 
facial skin, oral mucosa, teeth, 
cranial vessels, muscles and the 
temporomandibular joint are 
propagated via the trigeminal 
nerve. It enters the brain at the 
level of the pons and relays 
nociceptive information to 2
nd
-
order neurons via synapses 
located in nuclei of the trigeminal 
brainstem sensory nuclear 
complex (TBSNC) indicated by the 
red box. On the one hand, most of 
the 2
nd
-order neurons relay 
nociceptive input to the 
ventroposterior thalamic nucleus 
(VPM) of the thalamus. On the 
other hand, some 2
nd
-order 
neurons project to brainstem 
structures, such as the cranial 
nerve motor nuclei or the reticular 
formation. (Figure from Sessle, 
2000, modified by the author) 
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Already at the level of the dorsal horn and the TBSNC, nociception is subject to 
modulation and regulation (Sessle, 2000; Scholz and Woolf, 2002). In 
physiological conditions, signals are modulated by local circuits and through top-
down regulated efferents from pain-modulating networks in order to promote 
homeostasis (Tracey and Mantyh, 2007). Descending pain regulatory 
mechanisms are discussed in section 2.1.2.  
After being subject to a first modulation, nociceptive signals are projected in a 
smaller extent to brainstem and cerebellar structures. Most of the ascending 
nociceptive signals are projected to thalamic nuclei, where they are further 
transmitted to (sub-) cortical structures for final integration and interpretation. 
 
3.1.2 Brain networks involved in the creation and “coloring” of pain 
experience.  
The term nociception refers to the detection of tissue damage by specialized 
transducers attached to A-δ and C fibers including their modulation due to 
inflammatory processes described in the last section (Loeser and Melzack, 1999).  
In contrast, a pain experience is the outcome of the modulation and 
interpretation of nociceptive signals by the brain strongly influenced by various 
factors such as context, mood and cognitive characteristics (Figure 10).  
Ronald Melzack (1999) proposed the existence of a “pain neuromatrix”, often 
also termed pain matrix, a network of brain areas which represents the neural 
substrate of a pain experience. Since the advent of neuroimaging techniques, a 
multitude of studies have been conducted using fMRI and PET to identify such a 
network (Apkarian et al., 2005; Tracey and Mantyh, 2007). These studies 
managed to identify a multitude of regions that showed activity changes during 
acute pain experience. Various reviews summarize these findings (Peyron et al.,  
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2000; Apkarian et al., 2005; Farrell et al., 2005) . Figure 11 provides an overview 
of the identified brain structures commonly involved in pain perception. 
Yet, although this regions are frequently (depending on the experimental 
procedures) activated during pain perception, it does not mean that they are 
pain-specific, but rather that they, besides many other things, also process pain 
(Tracey and Mantyh, 2007). Pain stimuli are highly salient. As such they activate 
brain mechanisms involved in orienting the attention and body towards a 
stimulus, perception of the stimulus, evaluation of its unpleasantness and 
possible danger, triggering of memories, avoidance movement patterns etc. The 
same applies to other salient stimuli such as loud noises and bright flashes of 
light. Based on these assumptions it was not surprising when researchers found  
 
Figure 10: Illustration of the main processes involved in nociceptive modulation and the 
“coloring” of pain experience (Figure from Tracey and Mantyh, 2007; modified by the author). 
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strongly overlapping activity patterns between nociceptive somatosensory, non-
nociceptive somatosensory, auditory and visual stimuli (Mouraux et al., 2011).  
Although the pain research community mainly adopted the view of pain 
sensation being an emergent phenomenon linked to holistic brain activity 
patterns in the aforementioned brain regions, some researchers continue the 
quest for areas more specifically involved in the creation of the pain percept. The 
focus on areas with higher pain specificity is supported by deep brain stimulation 
Figure 11: Cortical and subcortical brain structures involved in acute pain perception. 
Interconnectivity and afferent pathways are illustrated by arrows. S1/S2 = primary/secondary 
somatosensory cortices, ACC = anterior cingulate, PF = prefrontal cortex. M1 = primary 
motorcortex, SMA = supplementary motor cortex, PPC = posterior parietal cortex, PCC = 
posterior cingulate, BG = basal ganglia, HT = hypothalamus, Amyg = amygdala, PB parabrachial 
nuclei, PAG = periaqueductal gray (Figure from Apkarian et al., 2005, modified by the author). 
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studies, where a vast area of the brain was electrically stimulated. In these 
studies, the stimulation of many of the above summarized areas failed to induce 
pain perceptions. The only structures which were associated with the perception 
of pain when stimulated were the posterior insula and the medial parietal 
operculum (Mazzola et al., 2012b). These findings have been further validated 
using fMRI by the same group (Mazzola et al., 2012a), providing evidence for 
pain specificity in a cytoarchitectonically distinct part of the posterior insula: The 
posterior granular part of the insula (mostly) contralateral to the stimulation site. 
The fMRI-study (study 3) conducted in the context of this doctoral thesis 
addresses this issue by applying a novel pain paradigm. The results provide 
evidence for a special role of the posterior insula in the percept of pain, hence 
being in line with the studies from Mazzola et al. (2012, 2012a).  
3.1.3 Built-In Loudness Control of Nociceptive Signals: The DPMS 
The brain possesses a powerful mechanism capable of modulating afferent 
nociceptive signals on the spinal cord and TBSNC level. This neural network is 
called the Descending Pain Modulatory System (DPMS) and is able of modulating 
the “gain” of nociceptive signals by facilitating or inhibiting signal transmission at 
the level of the spinal cord and TBSNC (Tracey and Mantyh, 2007; Ren and 
Dubner, 2011; Denk et al., 2014). The neurocircuitry of the DPMS is schematically 
depicted in figure 12. 
The core structures of the DPMS consist of two regions located in the brainstem: 
The periaqueductal gray (PAG) and the rostral ventromedial medulla (RVM).  
The PAG is considered to be the core structure of the opioid-based top-down 
pain modulation system, which is well studied on an experimental animal basis 
(Graeff and Del-Ben, 2008). It is subject to top-down regulation through 
connections to (sub-)cortical structures of the DPMS , such as areas from the 
frontal lobe, the thalamus, subregions of the anterior cingulate cortex,  
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hypothalamus and amygdala, all structures which also play a role in the 
formation of pain experiences (Tracey and Mantyh, 2007; Denk et al., 2014).  
The PAG projects to the rostral ventromedial medulla (RVM), which inhibits 
ascending nociceptive signals through its projections to the spinal cord and 
TBSNC through releases of noradrenaline and 5-hydroxytryptamine (5-HT) 
(Tracey and Mantyh, 2007; Ren and Dubner, 2011; Linnman et al., 2012; Denk et 
al., 2014). As previously mentioned, the PAG is also capable of facilitating 
nociceptive signaling through its projections to the nucleus cuneiformis 
(NCF)(Tracey and Mantyh, 2007). Pathological imbalances in the 
inhibitory/facilitatory functions are believed to play an important role in the 
development and persistence of chronic pain conditions, as shown by various 
animal studies (Denk et al., 2014). 
 
Figure 12: Schematic depiction of the 
descending pain modulatory system 
(DPMS). The DPMS consists of a 
network of brainstem structures: 
Nucleus cuneiformis (NCF), 
periaqueductal gray (PAG), 
dorsolateral pontine tegmentum 
(DLPT) and rostral ventromedial 
medulla (RVM). The DPMS is subject to 
top-down and bottom-up modulation 
(pink and green lines) and excerts pro- 
and antinociceptive influences on 
ascending nociceptive input (indicated 
by +/- symbols)(Figure from Tracey and 
Mantyh, 2007; modified by the 
author). 
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Top-down regulation of the DPMS is a highly dynamical process. Subjects’ 
participating in our pain studies typically show different levels of fluctuations in 
perceived pain intensity, despite the administered identical stimulus intensities. I 
often asked the participants during the psychophysical testing about the 
thoughts they had during the stimulation procedure. I frequently observed that 
the phasic changes in mind wandering, distraction, fear etc. reported by the 
participants correlated with the fluctuations in perceived intensities. 
Interestingly, a recent line of research has been investigating these effects of 
sustained attention to and mind-wandering away from pain and identified three 
neural systems which are key contributors to the ongoing dynamics of pain: The  
Figure 13: The concept of the dynamic pain connectome. A) Three neural networks are involved 
in the level of intrinsic attention to pain: The i) salience network (SN), the ii) default mode 
network (DMN) and iii) the antinociceptive system AS (also termed DPMS by others). B) During 
rest, attention to pain, or mind wandering away from pain, the three networks are engaged to a 
different extent. C) People with high or low intrinsic attention to pain (IAP) differ in their 
functional and structural connectivity between the DMN and AS. (From Kucyi & Davis, 2015)  
 
 
(Figure from Apkarian et al., 2005, modified by the author) 
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salience network (SN), the default-mode network (DMN) and the DPMS (Kucyi 
and Davis, 2015) (see sigure 13). It was found that during the attention to pain, 
the SN is strongly activated, probably due to the role of the SN in orienting 
attention towards external stimuli. However, during mind wandering away from 
pain, the DMN and the DPMS are both stronger engaged and functionally 
connected (Kucyi and Davis, 2015).  
Based on these findings, Kucyi and Davis (2015) developed the concept of 
“Intrinsic Attention to Pain” (IAP). In their concept, people can be ascribed to low 
and high IAP groups based on their intrinsic attention levels to pain sensations 
and their capability to mind wander away from pain sensations (Kucyi and Davis, 
2015). Interestingly, people from the low IAP-group show stronger functional 
and structural connectivity between the DMN and PAG compared to high IAP 
subjects, hence providing an anatomical and functional basis for their superior 
capability to disengage from pain perception. These findings provide compelling 
evidence for the importance of the DPMS in highy dynamic aspects of pain 
perception (Kucyi and Davis, 2015).  
 
3.1.4 Central Nervous Processes Involved in Chronic Pain 
There is no sole mechanism for the cause of chronic pain. In the contrary, chronic 
pain conditions may be associated with various dysregulatory processes along 
the whole pain-processing pathway, from the TBSNC/spinal cord to multimodal 
brain cortices.  
 
Local Aberrant Modulation of Somatosensory Stimuli at the Level of the Dorsal 
Horn and TBSNC.  
As previously mentioned in section 2.1.1, already at the 1st-order synapses in the 
spinal cord and TBSNC, nociceptive (and innocuous) inputs are subject to 
modulation. Misregulation including disinhibition and central sensitization can  
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occur at this level (Scholz and Woolf, 2002). Peripheral nerve injuries can result 
in various aberrant neuroplastic changes in the dorsal horn of the spinal cord and 
TBSNC which lastly may give rise to chronic neuropathic pain conditions (Sessle, 
2000; Scholz and Woolf, 2002). On the one hand, central terminals of myelinated 
non-nociceptive Aβ-fibres can sprout in the dorsal horn and synapse with 
nociceptive neurons (Figure 14). The synaptic alterations may result in the 
painful processing of otherwise innocuous afferents and hence contribute to 
persistent pain hypersensitivity (Scholz and Woolf, 2002). 
Figure 14: a) Alterations in synaptic connectivity in the spinal cord. Central terminals of 
myelinated non-nociceptive Aβ-fibers sprout in the dorsal horn and synapse with nociceptive 
neurons, leading to a painful experience of innocuous afferents. b) Disinhibition. Following 
peripheral nerve injuries, inhibitory interneurons can be lost due to excessive levels of 
excitotoxic amino acid glutamate. The loss of interneurons together with reductions in inhibitory 
neurotransmitter synthesis such as GABA and glycine increases the excitability of pain 
transmission neurons. As a consequence, these neurons begin to respond to usually innocuous 
stimuli (Figure from Scholz & Woolf, 2002, modified by the author). 
a) b) 
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On the other hand, examples from animal research show that chronic 
neuropathic pain resulting from nerve injury can be the consequence of the loss 
of dorsal horn inhibitory circuits (Figure 14)(Bráz et al., 2012). The loss of 
GABAergic interneurons leads to a loss of inhibition, manifesting itself as 
spontaneous pain but also as allodynia and hyperalgesia (Bráz et al., 2012). 
Further evidence is provided by the study from Bráz et al. (2012). In their study, 
the transplantation of immature telencephalic GABAergic interneurons from the 
mouse medial ganglionic eminence (MGE) into the adult mouse spinal cord 
reversed the mechanical hypersensitivity produced by peripheral nerve injury. 
In the same vein, orofacial neuropathic pain has been linked to local changes in 
the GABAergic inhibitory sytem in the nucleus caudalis of the TBSNC in animal 
models (Takeda et al., 2011; Sessle, 2016). 
 
DPMS-Mediated Aberrant Regulation of Nociceptive Signaling 
During the last decade, the DPMS has become a major research subject in regard 
to its prominent role in the perpetuation of chronic pain conditions. Under 
physiological conditions, facilitating and inhibiting efferents of the DPMS are 
believed to function in concert to create a balance in somatosensory modulation 
(Denk et al., 2014).  
However, different processes have been suggested which are capable of shifting 
the DPMS towards persisting facilitating mode, thus creating a pathological 
imbalance. Animal research points towards the loss of inhibitory and facilitatory 
balance in the DPMS. This loss of inhibition has been linked to plastic changes in 
its structures as a consequence of ongoing nociceptive signaling.  Exemplary are 
reported plastic changes in the RVM as a result of ongoing afferent input due to 
peripheral nerve injuries (Porreca et al., 2002). In addition, it has been suggested 
that enhanced facilitation may be due to an upregulation of NMDA receptors in 
the RVM due to persisting nociceptive inputs (Terayama et al., 2000).   
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Hence, a direct baseline assessment of the status of DPMS structures in humans, 
for example by the characterization of their neurochemical status, may provide 
important additional information about misregulatory processes in the DPMS. 
With regard to the PAG, some evidence suggests that glutamatergic and 
GABAergic systems may distinctively mediate facilitatory and inhibitory 
processes (Samineni et al., 2017). I hypothesize that the quantification of 
glutamate and GABA concentration in the human PAG may provide crucial 
information about the facilitatory/inhibitory balance in humans and should be 
subject to further 1H-MRS studies.  
Yet, there are some studies performed with humans which indirectly 
investigated the status of the DPMS. For example, studies investigating DMPS-
mediated processes such as noxious inhibitory control and pain temporal 
summation are predictive of the level of postoperative acute pain and of the 
level of risk for post-surgical chronic pain (Yarnitsky et al., 2008; Weissman-Fogel 
et al., 2009). 
 
(Sub-) Cortical Processes Involved in Chronic Pain 
Neuroimaging studies provided valuable insights regarding the altered 
connectivity between the DPMS and cortical structures linked to chronic pain 
patients. A multitude of studies point towards connectivity changes between 
attention-related cortical structures and the PAG (Kucyi and Davis, 2015). Based 
on the IAP-concept previously discussed in section 2.1.3, it is conceivable that 
the level of the intrinsic attention to and within its connectomics may constitute 
a mechanistic factor that alters structural and functional reorganization over 
time ultimately leading to misregulation of afferent somatosensory signals (Kucyi 
and Davis, 2015). In this vein, not only have anatomical changes (gray matter 
volume and cortical thickness) been found in regions of the DMN, salience 
network and DPMS in chronic pain populations (May, 2011; Davis and Moayedi, 
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2013), but also changes in functional connectivity within and between these 
networks has been identified in chronic pain disorders (Napadow et al., 2010; 
Baliki et al., 2011; Mainero et al., 2011; Bolwerk et al., 2013; Loggia et al., 2013; 
Baliki et al., 2014; Yu et al., 2014). 
Another (sub-) cortical system that has been linked to the etiology and 
manifestation of chronic pain is the reward network (Denk et al., 2014). In a 
longitudinal brain imaging study, subacute back pain patients were examined 
over the course of one year from the acute pain phase onwards. Pain persisted in 
12 patients, whereas pain improved in the other 12. Interestingly, the 
connectivity strength between the nucleus accumbens (NAc) and the prefrontal 
cortex (PFC) recorded at the beginning of the study during the acute pain phase, 
predicted the pain chronification by more than 80%. Furthermore, the increased 
connectivity between NAc and PFC remained unchanged during the 
chronification process (Baliki et al., 2012). Altogether, these findings point 
towards the involvement of the reward-mesolimbic-prefrontal circuitry in the 
transition to and continuation of chronic pain (Denk et al., 2014). 
Another study points towards the involvement of a structure usually associated 
with declarative memory declaration and consolidation: The hippocampus. The 
same group that identified the predictive nature of NAc-PFC connectivity in the 
chronification process also investigated the role of the hippocampus in the same 
longitudinal brain imaging data and found that the hippocampal-cortical 
connectivity differed between the pain remission and the pain persisting group. 
Specifically, the group with persistent pain over the time course of one year 
showed a large decrease in connectivity between the medial PFC and the 
hippocampus. Furthermore, the strength in hippocampal-medial PFC 
connectivity reflected variations in back pain intensity levels over the year 
(Mutso et al., 2014). 
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The importance and necessity of a multimodal approach in the investigation of 
the neural correlates of chronic pain is reflected in the work conducted by 
Henderson et al. (2013). They investigated the role of the thalamus as a central 
generator in the formation of neuropathic pain. Patients suffering from 
trigeminal neuropathic pain (due to nerve lesions caused in chirurgical 
interventions) and healthy controls were compared using an array of 
neuroimaging methods such as voxel-based morphometry (VBM), arterial spin 
labeling (ASL) and 1H-MRS. They found a reduction in the gray matter density 
accompanied by a decrease in blood perfusion (Henderson et al., 2013). 
Interestingly, the reduction in gray matter volume and cerebral blood flow in the 
thalamus was accompanied by a highly significant reduction in GABA 
concentrations in the thalamus. The combination of the 1H-MRS and ASL data 
revealed significant changes in the functional connectivity (in 
primary/somatosensory cortices, anterior insula, primary motorcortex and 
cerebellum) between the thalamus and cortical pain processing regions in 
dependence of GABA concentrations, indicating towards a reduction in 
nociceptive inhibition. These changes were only observed in the neuropathic 
pain condition, but not in the healthy participants.  
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4 1H-MRS in Human Pain Research –Potential and Pitfalls 
This chapter aims at discussing the potential and challenges of 1H-MRS for 
answering important questions in pain research. Firstly, examples are given 
where 1H-MRS can provide valuable contributions to the field of pain research. 
And lastly, the pitfalls and challenges of 1H-MRS in pain studies (and studies in 
general) are discussed.  
 
4.1 Valuable Contributions of 1H-MRS to Pain Research 
In the previous chapters, a basic overview was presented about the brain 
processes underlying physiologic and pathologic pain processing.  
When looking at the research conducted at different levels of the CNS, it 
becomes apparent that types of research are somewhat segregated along the 
neuraxis. Our knowledge about brainstem processes like neurochemical and 
cellular mechanisms involved in physiologic nociceptive modulation in health and 
disease is mostly based on animal research. Few studies on human pain-related 
structures have been conducted at the level of the brainstem using MR-imaging 
techniques such as fMRI and DTI (DaSilva et al., 2002; Upadhyay et al., 2008; 
DaSilva and DosSantos, 2012; Mills et al., 2018). Although these studies provide 
important insights, the transfer of some of the findings provided by animal-based 
studies remain unmet regarding humans. Although functional processes between 
the TBSNC and regions of the DPMS were investigated using fMRI, such 
investigations still lack the necessary “depth” to elucidate underlying 
neurochemical processes. The application of 1H-MRS may thus be a viable option 
to bridge animal and human research on brainstem mechanisms.  
In order to clarify this perspective, animal research on the TBSNC shall be taken 
as an example. Normal nociceptive processing in the TBSNC has been linked to 
excitatory neurotransmittory processes such the activation of NMDA receptors 
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via glutamate (Sessle, 2000). On the chronification side, models of trauma, 
inflammation and nerve constriction injuries point towards the involvement of 
changes in the GABAergic system. In order to evaluate treatment efficiency and 
develop new treatment options, it is important to understand how these 
neurotransmitter systems act in health and in chronic orofacial pain conditions 
such as trigeminal neuropathic pain. Thus, as 1H-MRS grants access to glutamate 
and GABA concentrations, it may hold the potential to provide such crucial 
information and fosters the obtainment of new findings, the prerequisite to 
more specific treatment development and evaluation.  
In the same vein, animal research focusing on the DPMS also suggests the 
existence of different neurotransmittory systems involved in the 
facilitatory/inhibitory homeostasis of nociceptive regulation (Samineni et al., 
2017). Therefore, the in-vivo assessment of such neurotransmittory systems 
using 1H-MRS may help shedding light in possible dysfunctional states in the 
DPMS in humans. 
Also regarding the complex functional dynamics of pain processing between 
(sub-) cortical areas identified with fMRI or ASL, 1H-MRS might be highly auxiliary 
as a complementary technique for a multimodal investigation of brain dynamics. 
The previously reported study conducted by Henderson et al. (2013) shall be 
taken as an example. In their work, they showed that baseline levels of GABA in 
the thalamus were predictive for the functional connectivity strength between 
the thalamus and other cortical pain-processing regions. In that vein, 1H-MRS 
could be applied as a complementary method to explain the nature of functional 
connectivity patterns by adding a neurochemical component to the fMRI or ASL 
analysis.  
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4.2 Pitfalls and Challenges of 1H-MRS in Pain Research 
The pitfalls and challenges of 1H-MRS presented in the following sections are not 
specific to pain research and hence are common to neuroscientific investigations 
in general.  
4.2.1 Anatomical and Functional Specificity 
Single-voxel 1H-MRS is usually applied to a-priori defined brain regions based on 
an underlying scientific question. However, the sensitivity and accuracy to 
appropriately answer a scientific question strongly depends on the specificity of 
the voxel.  
As an example, the insular cortex as a whole is strongly involved in various 
aspects of pain processing. Yet, subregions of this cortical structure are 
distinctively involved in the processing of different pain facets. The insular cortex 
has been segmented into subregions based on their cytoarchitectonic 
organization. From these defined subregions, the posterior granular 
compartment (lg) shows a superior specificity to pain compared to the other 
types of somatosensory input (Figure 15) (Mazzola et al., 2012a). In that vein, the 
application of 1H-MRS to the posterior insula could significantly contribute to the 
question of pain specificity in the posterior by unveiling possible neurochemical 
underpinnings underlying the observed effects.  
However, as previously discussed in section 2.1.2, voxels applied in 1H-MRS 
investigations have a typical size of 8cm3 (Figure 16). In regard to the example 
with the posterior insular subarea, such voxel dimensions would be impractical 
as it would include surrounding structures, possibly lacking the same pain 
specificity. As a consequence, it is conceivable that with such voxel dimensions 
the results would not provide any evidence for a hypothezized specific role of the 
posterior insular subarea in pain processing.  
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During the preparation of such a study, it may be useful to conduct 
reproducibility analyses in order to determine the impact of optimal voxel 
dimensions on data quality, fitting errors and the resulting sensitivity of the 
method in detecting differences in neurochemical compound concentrations. As 
shown in our reproducibility study (de Matos et al., 2016), the reduction of voxel 
dimensions to an acceptable specificity level does not have to go along with bad 
reproducibility.  
Figure 15: Group activation maps corresponding to various stimulation types applied to the left 
hand. The insular cortex and adjacent parietal operculum are segmented based on 
cytoarchitectonical criteria. The only regions showing pain-specificity was the opercular area 3 
(OP3) and the posterior granular compartment of the insula contralateral to the stimulation site 
(blue circle) (Figure from Mazzola et al, 2012a, modified by the author).  
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The inclusion of unwanted brain areas and tissue types into the measurement 
voxel is called partial volume effect (Stagg, 2013). The previous example 
illustrates possible consequences of the inclusion of areas other than the 
intended region, which could result in the masking of the effects of interest. Yet, 
the aspect of the ratio of gray matter (GM), white matter (WM) and 
cerebrospinal fluid (CSF) in the voxel is also of importance. As most 
neuroscientific investigations using 1H-MRS focus on GM processes such as 
neurotransmission, any contribution of WM and CSF to the signal reduces the 
sensitivity with respect to GM specific processes/mechanisms.  
8cm3
3cm3
Figure 16: Comparison of voxel specificity in the posterior insula of a typical 8 cm
3
 voxel (yellow 
boxes) and a more specific voxel with a 3 cm
3
 volume (red boxes). The 8 cm
3
 sized volume shows 
large levels of partial volume effects due to the inclusion of unwanted regions such as the 
claustrum, temporal gyri and parietal operculum. Furthermore, the bigger volume contains 
larger contributions from CSF and white matter, hence further reducing its specificity.  
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4.2.2 Systematic Errors in Quantification 
Variation in SNR and LW can cause systematic errors in the spectrum 
quantification such as over- and underestimation of neurochemical 
concentrations in dependence to SNR and LW (Kanowski et al., 2004; Bartha, 
2007; Henry et al., 2011; Hong and Pohmann, 2013). Hence, it is of outmost 
importance to keep differences in SNR and LW between experimental groups 
and conditions to a minimum. On the one hand, as described in section 2.1.5, the 
use of thresholds for SNR and LW for data inclusion may be beneficial in reducing 
such differences due to the exclusion of outlier spectra.  
On the other hand, the filtering of spectra in the time domain might be necessary 
to reduce systematic differences in SNR and LW between conditions. Functional 
1H-MRS studies investigating neurochemical responses to a certain task or 
stimulus (like pain) can be affected by changes in the hemodynamic response. 
As described in the introduction of this thesis, neuronal activity modulates local 
blood perfusion changing the ratio of oxyHb to deoxyHb. A body of evidence 
suggests that 1H-MRS is also influenced by hemodynamic responses (Zhu and 
Chen, 2001; Mangia et al., 2007; Koush et al., 2013; Mumuni and McLean, 2017).  
In fMRI, this process constitutes the underlying mechanism for the identification 
of brain activity. However, the effect on 1H-MRS is usually less favorable as it 
directly affects spectral resolution. Changes in the oxyHb/deoxyHb ratios affect 
the duration of the FID. With the overcompensation in oxyHb due to the 
hemodynamic response, the FID becomes longer, resulting in reduced LW. As a 
consequence, spectral resolution may become improved due to increases in 
blood perfusion, lastly causing differences in spectral LW between experimental 
conditions. The application of MC-PRESS in functional studies is advantageous 
due to the conservation of both, the neurochemical and water peaks. As the 
water signal is acquired simultaneously to the neurochemical signal, it is affected 
by the same hemodynamic influences. Hence, the water spectrum of one of both 
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conditions can be filtered to match the water LW of the other condition, 
automatically removing LW differences in the neurochemical spectrum (Matos et 
al., 2017).  
4.2.3 Physiology-Dependent Signal Disturbances  
Structures in the human brainstem are particularly difficult to investigate due to 
the strong arterial and CSF pulsation arising from surrounding structures. 
Pulsation causes shifts in B0, shifting the larmor frequencies of the 
neurochemicals of interest. As a result, spectral linewidths are reduced. 
In addition, as brainstem regions are usually very small in their size, small voxels 
must be applied to guarantee an acceptable level of anatomical specificity. The 
downside of the small voxel sizes is that longer measurement times are needed,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: This picture shows the distribution of 512 water peaks from a TBSNC measurement in 
the brainstem a) after and b) before peak realignment. In b), water peaks are distributed due to 
frequency shifts caused by various changes in B0. After realignment, spectral resolution is 
improved, enabling the quantification of neurochemical information (unpublished data from our 
TBSNC-
1
H-MRS study).   
a) 
b) 
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thus adding additional B0-shifts due to B0-drifts and participant movement.  
MC-PRESS provides the possibility to align, phase and eddy current correct single 
spectra before averaging, thus minimizing the impact of these different sources 
of B0-changes during the data acquisition (Figure 17).  The application of MC-
PRESS in our TBSNC-study was the crucial point to accurately obtain important 
neurochemical effects in the brainstem.  
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5.1.1 Abstract 
 
The current report assessed measurement reproducibility of proton magnetic 
resonance spectroscopy at 3 Tesla in the left and right posterior insular, 
pregenual anterior cingulate and anterior midcingulate cortices. 10 healthy male 
volunteers aged 21 to 30 years were tested at four different days, of which 9 
were included in the data analysis.  
Intra- and inter-subject variability of myo-inositol, creatine, glutamate, total-
choline, total-N-acetylaspartate and combined glutamine-glutamate were 
calculated considering the influence of movement parameters, age, daytime of 
measurements and tissue composition.  
Overall mean intra-/inter-subject variability for all neurochemicals combined 
revealed small mean coefficients of variation across the four regions: 5.3/9.05% 
in anterior midcingulate, 6.6/8.84% in pregenual anterior cingulate, 7.3/10.00% 
in left posterior and 8.2/10.55% in right posterior insula. Head movement, tissue 
composition and day time revealed no significant explanatory variance 
contribution suggesting a negligible influence on the data. A strong correlation 
between Cramer-Rao Lower Bounds (a measure of fitting errors) and the mean 
intra-subject coefficients of variation (r=0.799, p<0.001) outlined the importance 
of low fitting errors in order to obtain robust and finally meaningful 
measurements.  
The present findings confirm proton magnetic resonance spectroscopy as a 
reliable tool to measure brain neurochemistry in small subregions of the human 
brain. 
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5.1.2 Introduction 
Neuroimaging taught us a lot about functional principles of the human brain with 
functional magnetic resonance imaging (fMRI) as leading edge technology. 
Proton magnetic resonance spectroscopy (1H-MRS) represents another non-
invasive magnetic resonance based method. In contrast to fMRI, which relies on 
relative changes of blood oxygenation, 1H-MRS is able to directly detect and 
quantify neurochemical components of the living brain. This method provides 
information about energy metabolism (creatine/phosphocreatine, glucose and 
lactate), membrane metabolism and integrity (choline) as well as 
neurotransmission (glutamate, N-acetyl-aspartyl-glutamate, glutamine, GABA, 
aspartate and glycine). N-acetylaspartate and myo-inositol are thought to reflect 
neuronal and astroglial markers whereas ascorbic acid and gluthatione provide 
the in-vivo antioxidant profile (Stagg and Rothman, 2013). Compared to fMRI as 
the mainstay of neuroimaging, 1H-MRS thus holds the potential to provide 
important and complementary (to fMRI) insights with respect to understanding 
neurochemical related functional principles of the human brain in both, health 
and disease.  
However, application of 1H-MRS poses several challenges. Generally, the signals 
are very minute making spectrum quality and succeeding interpretation of 
acquired data a critical issue (Kreis, 2004). To compensate for this major 
constraint, frequently applied volumes of interest - termed voxel - are about 8 ml 
in size. But, such voxel sizes are often too big to optimally capture relevant brain 
structures considering their functional and anatomical specifications (Stagg and 
Rothman, 2013). Exemplary are cingulate and insular brain areas with their 
corresponding subdivisions. They are crucially involved in a multitude of brain 
functions reflected in high citation rates across the literature by covering an 
impressive discipline variety. For example, significant functional contributions of 
these subareas have been demonstrated in chronic (Denk et al., 2014) and acute 
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pain (Apkarian et al., 2005; Vogt, 2009; Wager et al., 2013), attention deficit 
hyperactivity disorder (Bush, 2011), anxiety (Damsa et al., 2009), depression 
(Fountoulakis et al., 2008; Su et al., 2014) and schizophrenia (Takahashi et al., 
2003; Haznedar et al., 2004; Costain et al., 2010). 
Importantly, a considerable body of literature emphasizes anatomical and 
functional heterogeneity within those gross cingulate and insular areas. For 
example, current consensus subdivides the coarse cingulate cortex into six 
subregions based on cytoarchitectonic and associated functional characteristics 
(Vogt, 2005, 2009; Dou et al., 2013). In a similar vein, subdividing of the insular 
cortex into an (at least) anterior and posterior compartment is strongly 
recommended based on structurally and functionally known attributes (Varnavas 
and Grand, 1999; Kurth et al., 2010b; Kurth et al., 2010a; Stephani et al., 2011; 
Mazzola et al., 2012a; Mazzola et al., 2012b; Nieuwenhuys, 2012). 
For obtaining more meaningful 1H-MRS measures, voxels should therefore cover 
functional homogeneous cingulate and insular subregions as distinctly as 
possible (Dou et al., 2013; Gutzeit et al., 2013). 
The critical points are that such subregion dimensions clearly are below 8 ml, and 
applicable 1H-MRS volumes are limited to cuboid shapes. Those two aspects 
hamper adequate anatomical coverage of the target areas because gyrification 
and structure contours are mostly bent.  Consequently, voxels should be even 
smaller than the actual target areas to ensure appropriate anatomical (and 
functional) specificity.  
Additionally, besides covering the desired gray matter (GM), they also include 
white matter (WM) and cerebrospinal fluid (CSF). Hence, measured signals 
derived from all these tissue components induce another source of uncertainty 
regarding meaningful interpretation of the underlying area’s specific 
neurochemistry (Stagg and Rothman, 2013) (in fMRI studies, this issue is 
circumvented by specific tissue segmentation strategies implemented in all 
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analysis software packages, but this practice is not yet common in  1H-MRS 
reports). Therefore, when applying such small voxels in an attempt to optimally 
capture relevant brain subregions, it must be clarified as to whether quality 
aspects of 1H-MRS measurements are affected in order to gain the appropriate 
information with respect to the neurochemical milieu within the target areas.  
This study was conceptualized to explore 1H-MRS measurement reproducibility 
in anatomically and functionally homogenous subregions of cingulate and insular 
cortices, all substantially below 8ml. Areas investigated were: Pregenual anterior 
cingulate (pgACC), anterior midcingulate (aMCC), as well as left and right 
posterior insular cortex (pIL and pIR). Measurements were conducted using 
standard MR-equipment and 1H-MRS sequences at 3 Tesla in order to allow 
application and replication in commonly available clinical and research settings.  
 
5.1.3 Materials & Methods 
The present study was approved by the local ethics committee and conducted 
according to the Declaration of Helsinki. 
 
Subjects and Experimental Procedure 
10 healthy male volunteers (mean age = 25.3, range: 21-30) were recruited for 
the study. Exclusion criteria were general contraindications for MR, neurologic 
and psychiatric diseases as well as any form of pain conditions. Every subject 
attended four scan visits on different days (mean intersession interval = 11.03 d; 
SD = 10.98; range = 1-42 d). All acquisitions (except for one measurement which 
was performed at 2:00 PM) were conducted at one of four time slots in the 
afternoon and evening (Time slot 1: 4:00 - 5:30 PM; Time slot 2: 5:30 – 7:00 PM; 
Time slot 3: 7:00 – 8:30 PM; Time slot 4: 8:30 – 10:00 PM). The overall mean 
starting time was 5:47 PM (SD = 1h 44 min).  
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Subjects received detailed information about the experimental procedure, aim of 
the study and provided written informed consent. Participants were informed in 
detail about the importance of remaining as motionless as possible during the 
scan sessions. They were further instructed not to consume alcohol, analgesic 
medication and other drugs on examination days as well as to be fed. 
 
Scanning 
Subjects were comfortably positioned in the scanner in a supine position. The 
Pearltec Crania (Pearltec AG, Schlieren/Zurich, Switzerland) head fixation system 
was applied for an optimal and comfortable head fixation. MR measurements 
consisted of a survey scan, a T1-weighted anatomical scan for precise voxel 
placement and tissue segmentation (duration = 7 min 29 s) followed by four 
consecutive single-voxel MRS measurements in the four target areas (duration = 
approximately 6 min each). To consider possible head movements, an adapted 
short T2-weighted image (duration = 21s) was recorded before and after each 
MRS sequence in order to estimate the extent of voxel displacements. The 
measurement order of the brain regions was alternated between the four 
measurement days to account for measurement order effects and frequency 
drifts due to heating and other time dependent MR-system changes. The total 
duration of the MR measurements was approx. 45 min. 
 
MR protocols 
MR experiments were performed on a 3-Tesla MR unit (Ingenia, Release 4.1.3, 
Philips Healthcare, Best, The Netherlands) utilizing a dS-SENSE 15-channel head 
coil (Philips Healthcare, Best, The Netherlands). Parameter of the T1-weighted 
turbo gradient echo sequence for voxel placement and segmentation were: 
TR/TE = 8.1/3.7 ms; flip angle = 8°; FOVFHxAP = 240x240mm; 160 slices; 
recorded voxel size = 1mm isometric. To calculate possible head movements, a 
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short T2-weighted turbo spin-echo sequence (<30s) was performed in axial 
orientation with the following parameters: TR/TE = 3000/80 ms, flip angle = 90°; 
FOVAPxRL = 230 x 182 mm; resulting voxel size = 1 x 1 x 4 mm. 
For the MR spectra acquisition, a conventional single-voxel PRESS (point-resolved 
spectroscopy) sequence (TR/TE = 2500/32 ms; data points = 1024; sample 
frequency = 2000 Hz; readout duration = 512 ms; number of acquisitions = 128) 
was used. A water-unsuppressed spectrum recorded with 16 acquisitions was 
acquired prior to the main spectrum for post-hoc spectral corrections. Water 
suppression was achieved using a VAPOR (variable pulse power and optimized 
relaxation delays) scheme. An implemented automatic second-order projection-
based shimming routine (Gruetter, 1993) was used for the reduction of B0-
inhomogeneities.  
The pgACC and aMCC voxels were carefully placed according to suggestions from 
specific literature (Vogt, 2005, 2009). The respective dimensions were: pgACC 12 
x 16 x 18 mm (AP x LR X FH; 3.46 ml), aMCC 23 x 15 x 12 mm (4.14 ml). Voxel 
placements for left and right posterior insular subdivisions were based on neuro-
anatomic and functional work (Varnavas and Grand, 1999; Kurth et al., 2010a; 
Mazzola et al., 2012a; Nieuwenhuys, 2012). They were placed posterior and 
aligned to the insular central sulcus including the gyri longi leading to voxel 
dimensions of 12 x 11 x 23 mm (3.04ml). Voxel placement was always performed 
by the same person (NM)(Figure 1). 
 
Quantification of spectroscopic data 
Spectroscopic data were quantified with LCModel (Provencher, 1993) using a 
basis set for an echo time of 32 ms including the following in vitro neurochemical 
model spectra: N-acetylaspartate (NAA), N-acetyl-aspartyl glutamate (NAAG), 
glutamate (Glu), glutamine (Gln), γ-aminobutyric acid (GABA), glutathione (GSH), 
glycerophosphocholine (GPC), phosphocholine (PCh), creatine (Cre), myo-Inositol  
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 (mI), ethanolamine and phosphorylethanolamine (PE), aspartate (Asp), glucose 
(Glc), lactate (Lac), scyllo-inositol (sI) and taurine (Tau). Substances with strongly 
overlapping spectra were combined to single spectra in order to improve 
quantification accuracy: Glu + Gln = Glx, GPC + PCh = tCho and NAA + NAAG = 
tNAA. The chemical shift range for the fitting procedure was set to 4.0-0.2 ppm. 
Fitted neurochemical concentrations were scaled to the internal water signal 
obtained from the corresponding water-unsuppressed spectrum acquisition. For 
all subsequent analysis steps we included the following neurochemicals, which 
demonstrated Cramér-Rao lower bounds (CRLB) <20%: mI, Cre, Glu, tCho, tNAA, 
Glx. A correction was applied to account for the fact that metabolic signals 
originate mainly from WM and GM but not from cerebrospinal fluid (CSF) 
(McLean et al., 2000). For this purpose, the T1-weighted anatomical images were 
segmented into brain tissue compartments (GM, WM, CSF) using the 
segmentation routine included in the SPM8 software package 
Figure 1: Representative illustration of a voxel positioning on sagittal and coronal plane images in 
a single subject.  a) pregenual anterior cingulate cortex (pgACC), b) anterior midcingulate cortex 
(aMCC), c)  left posterior insula (pIL), d) right posterior insula (pIR). 
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(http://www.fil.ion.ucl.ac.uk/spm) running on MATLAB 2013b (MathWorks, 
Natick, USA). The calculation of tissue fractions in the applied spectroscopic 
voxels were performed using a self-written MATLAB script. The neurochemical 
concentrations (C0) were corrected applying the following equation using the 
estimated fraction of CSF (FCSF) (McLean et al., 2000): 
 
C = C0 * (1/(1 – FCSF)). 
 
Head movement analysis 
Anatomical T2-weighted scans were analyzed to track possible head movements 
between spectroscopic acquisitions using the realignment function included in 
the SPM8 software package (http://www.fil.ion.ucl.ac.uk/spm) running on 
MATLAB 2013b (MathWorks, Natick, USA). Defining the first anatomical scan as 
reference, following scans were realigned to it providing estimates for 
translational (mm) and rotational (deg) displacements in the x, y and z-axis over 
time. 
In the next step, maximum displacements in the three translational and 
rotational orientations were determined for each individual session and then 
averaged over all sessions. This approach provides a more stringent evaluation of 
possible movement interference compared to mean intra-session displacements, 
as it represents more accurate strong head movements.  
  
Statistical and reproducibility analyses 
Statistical analyses were carried out with the SPSS Statistics 22 software package 
(IBM Corp., Armonk NY, USA).  
Mean neurochemical concentrations between the four spectroscopy acquisitions 
were compared with a repeated measure ANOVA (rmA). 
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In addition, reproducibility was determined by estimating the magnitude of intra- 
and inter-subject variability by means of coefficients of variation (CV, calculated 
as SD/Mean*100). 
CV is preferable to other dispersion measures due to its independence of the 
underlying scale (Lovie, 2005).  
Measures of reliability like the intraclass correlation (ICC) have also been used in 
MRS studies. The problem with this measure is its dependence on variation of a 
trait (like true differences in neurochemical concentrations between persons) in 
the measured populations, thus impeding a direct comparison of ICC values from 
different studies (Müller and Büttner, 1994; Henriques et al., 2013). In this vein, a 
heterogeneous population could yield higher (more reliable) ICC than a 
homogeneous population despite similar intra-subject variability. We therefore 
decided not to apply this measure in our study. 
Inter-subject variability was calculated by randomly selecting one time point 
from the four repeated measures of all participants and calculating mean and 
standard deviation. This step was repeated 5000 times to account for different 
combination possibilities. Afterwards, the 5000 means and SDs were averaged. 
The resulting means and SDs were used to calculate the inter-subject CV.  
Variations in GM/WM-ratio, daytime of participation and magnitude of between 
session movements contribute to intra-subject variability (Kreis, 2004; Soreni et 
al., 2006). Despite the applied precaution to control such effects, they might still 
have influenced variability. In order to estimate their effects, an ANCOVA with 
participants and regions as fixed effects (to account for variance attributable to 
participant and region characteristics) was calculated with GM/WM-ratio, 
daytime of participation and the absolute voxel displacement (d) as covariates. 
The vector representing the voxel displacement was calculated as follows:  
 
    √         
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X, Y and Z correspond to the three directions of the voxel displacement; 
therefore d is the vector of the three displacement directions describing the 
absolute voxel displacement. 
5.1.4 Results 
One participant had to be excluded due to problems with the tissue 
segmentation procedure, resulting in nine full data sets with a total of 36 spectra 
per region. 
 
Movement 
Results from the head movement analysis are summarized in Table 1. The 
displacement during the sessions was minute, with maximal shifts of 1.5 mm in 
the X-axis, 1.51 mm in the Y-axis and 1.43 mm in the Z-axis (mean of max.  
displacements: 0.31±0.23mm (X); 0.43±0.24mm (Y); 0.77±0.37mm (Z)). The 
estimated maximal rotational changes were negligible with max. rotations of 
2.51° in the pitch, 0.79° in the roll and 1.78° in the yaw-angle. We therefore 
expect head movement to be an insignificant source of variation. 
 
Spectral quality, fitting errors and tissue fractions 
One important aspect of chosen voxel dimensions was the maximization of grey 
matter tissue portion to enhance tissue specificity and account for partial volume  
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effects. The results from the tissue segmentation procedure are shown in table 
2. Highest GM contents were found in the pgACC voxels (80.85%), the smallest in 
the aMCC voxels (74.58%). Accordingly, WM percentages were small with mean 
values between 8.48% (aMCC) and 4.29% (pgACC). The remaining contributions 
from CSF were between 16.86% (aMCC) and 14.77% but are insignificant due to 
the applied CSF-correction. 
Differences in tissue percentages between the four sessions could increase intra-
subject variability. However, intra-subject differences of GM fractions between 
the four measurement repetitions were minimal with a mean CV of 1.83% over 
all participants and regions. We were able to record high quality spectra using 
small voxel sizes (3.04-4.14 ml) and moderate number of acquisitions (128). The 
level of SNR in the spectra was between 11.28 (pIR) and 16.00 (aMCC). The mean  
linewidth of the unsuppressed water signal was <0.054 ppm for allregions except 
for the pgACC (0.071 ppm). 
The good data quality resulted in overall small CRLBs although higher fitting 
errors were observed in the posterior insulae compared to aMCC and pgACC 
(Table 3). 
 
Reproducibility 
Figure2 provides a descriptive visual illustration of the four repeatedly acquired 
spectra in a given subject. Figure3 illustrates the overview of intra- and inter-
subject variations of neurochemical concentrations over all subjects. Differences 
in neurochemical concentrations between the four intra-individual 
measurements were analyzed by means of an ANOVA for repeated measures 
and no significant differences were found. Estimates of intra-subject and inter-
subject variability are summarized in table 3. The overall intra-subject variability 
was low with mean CV per region over all reported neurochemicals of 5.3%  
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(aMCC), 6.6% (pgACC), 7.3% (pIL) and 8.2% (pIR). Over all regions, the least 
variation was observed for tNAA (4.42%) whereas the largest variation was 
observed for mI (9.12%). 
Inter-subject variability showed a similar pattern with mean CV over all reported 
neurochemicals of 9.05% (aMCC), 8.84% (pgACC), 10.00% (pIL) and 10.55% (pIR).  
tNAA showed the least mean variability (CV = 7.18%) over all subareas whereas 
mI had the largest mean dispersion (CV = 14.23%). Differences between intra- 
and inter-subj. CV were smaller than expected, with a mean difference of just 
2.75%, pointing towards minimal subject-specific differences in neurochemical  
Figure 2: Exemplary depiction of spectral intra-subject variability based on representative spectra 
of one participant. The time interval between each of the 4 sessions was 7 days.  Spectra 
belonging to the four sessions are illustrated using different colors. Dark lines in the spectra 
represent the LCModel fit; brighter lines show the underlying raw data. 
 
 64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
concentrations. The small inter-subject effect might be attributable to the 
homogeneous group of participants tested.  
 
Figure 3: Intra- and inter-subj. variation of neurochemical concentrations illustrated by means of 
dot plots. Dots represent individual measurements; the horizontal black bars represent the mean 
of the four measurement days. The X-axis represent the subject number, the Y-axis represent the 
metabolite concentrations in arbitrary units (A.U.) aMCC = anterior midcingulate cortex, pgACC = 
pregenual anterior cingulate cortex, pIL/pIR = posterior insula left/right. 
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To test different sources of intra-subject-variability (GM/WM ratio, daytime of 
participation and head movements), an ANCOVA with participants and regions as  
fixed effects was conducted using these variables as covariates. This calculation 
revealed no significant explanatory contribution of variance by the covariates 
confirming their negligible effect on the data.  
In order to estimate the impact of the fitting error expressed as CRLBs, a pearson 
correlation analysis was performed between mean intra-subject CV and mean 
CRLB over all neurochemicals for the four regions (figure 4) (according to Geurts 
et al., 2004), revealing a significant positive correlation (r=0.799, p<0.001). 
5.1.5 Discussion 
The current report explored reproducibility of 1H-MRS at 3T in the following 
subregions of the cingulate and insular cortices: Pregenual anterior cingulate 
(pgACC), anterior midcingulate (aMCC) cortices as well as left and right posterior 
insula (pIL and pIR).  Results confirm that important neurochemical compounds 
are reliably quantifiable intra- and inter-subjectively over four measurement 
sessions on different days. In favor of a better overview, the discussion will be 
Figure 4: Scatterplot illustrating 
the positive correlation between 
mean intrasubject CV and mean 
CRLBs. Data points represent the 
six neurochemicals, data point 
shape and colours correspond to 
the four brain regions. r = 0.779; 
R
2 
= 0.6382.  = aMCC,  = 
pgACC,  = pIL,  = pIR. 
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categorized into four sections: 1) Specificity, 2) data quality, 3) intra-subject 
variation and 4) inter-subject variation. Afterwards, the results will be discussed 
in a broader context. 
 
Specificity 
In the present context, the term specificity encompasses 1) the accurate 
positioning of the voxels within the anatomical borders of aMCC, pgACC, pIL and 
pIR, 2) the achievement of a high gray matter (GM) percentage and 3) is further 
referred to the exact voxel repositioning across the four measurement days.  
Regarding 1), to remain as precise as possible within the regions specific 
anatomical borders, applied voxel sizes resulted in 3.46/4.14 ml for pgACC/aMCC 
and 3.04 for pIL/pIR. In terms of both cingulate subareas, we followed the 
classification scheme suggested by Vogt and colleagues (please see the methods 
section "Definition and placement of Voxels") as practically as possible. However, 
note that according to ex-vivo anatomical topography, the unilateral pgACC 
possesses volumes of about 6.4 ml, and the unilateral aMCC volumes of about 
4.3 ml (talairach space)(Vogt, 2009). In order to remain clearly within the 
anatomical borders together with the limitation of cuboid voxel shapes, the 
revealed volumes in this report were smaller with 3.46 for the pgACC and 4.14 
for the aMCC subareas. Particularly, the pgACC voxel is much smaller than the 
reported ex-vivo anatomy based volumes reasoning in the contour of this 
subdivision: it is heavily bent and hence we were coerced to reduce voxel 
dimensions in order to clearly remain within the pgACC borders. With respect to 
the aMCC, it was possible to cover the effective shape of this subregion rather 
accurately as it is a less bent cingulate subarea (see figure 1).  
For the pIL and pIR, sizes of 3.04 ml were finally used to approximate the 
anatomical borders as exactly as possible following several anatomical and 
functional reports (please see the methods section "Definition and placement of 
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Voxels"). Please note that the remaining voxels of the posterior insulae 
contained (however, to a small extent) tissue from surrounding areas (see fig. 1) 
due to gyrification and anatomical shape of adjacent gyri and temporal located 
areas. This situation combined with the cuboid voxel issue impeded an even 
more precise voxel positioning. Higher anatomical specificity might be attainable 
by further reducing voxel dimensions, however, with critical SNR costs, requiring 
very long acquisition times hardly applicable for in-vivo measurements. Other 
specificity enhancement strategies are under development and partly usable i.e. 
arbitrary voxel shapes. This strategy allows drawing of the region of interest 
along its exact contours, thus a high spatial selectivity can be theoretically 
achieved (Weber-Fahr et al., 2009; Snyder et al., 2012).  
Regarding 2), results from the tissue segmentation analysis confirmed high GM 
fractions in our volumes with percentages of 74.58% (aMCC), 80.85% (pgACC), 
77.62% (pIL) and 77.68% (pIR). Being able to delineate high GM contents are of 
particular importance for a multitude of basic neuroscientific/clinical questions 
as it increases sensitivity for the observation of neurochemical processes 
associated with neural activity (eg. Synaptic transmission, energy metabolism 
etc. Mangia et al., 2007b; Mangia et al., 2007a; Gussew et al., 2010) and GM-
specific structural changes (eg. loss of neurons indicated by decreases of 
NAA)(Stagg and Rothman, 2013).  
Point 3 can only be indirectly addressed, but small mean GM variations in the 
voxels (pgACC: 1.61%, aMCC: 1.44%, pIL: 2.15%, pIR: 2.11%) across the four 
measurement days over all subjects indicate fairly small differences in voxel 
repositioning.  
 
Data quality 
The quality properties of acquired spectra depend on a multitude of variables 
(for review see Kreis, 2004). Main criteria are peak linewidth and SNR which are 
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directly linked to voxel sizes. The smaller the voxel, the more negatively SNR is 
influenced, leading to lower spectral quality. In this report, voxel sizes from 3.04-
4-14 ml were applied and revealed acceptable to good spectral quality reflected 
in SNRs from 11.28 (pIR) to 16.00 (aMCC). On the contrary, spectral resolution 
can benefit from reduced voxel dimensions by a facilitation of B0-shimming. An 
enhanced shim allows for narrower and higher peaks enhancing neurochemical 
peak discrimination and resulting in better SNR (Kreis, 2004).Therefore, SNR loss 
due to reduced voxel dimensions can be partly compensated by improved 
shimming (Hock et al., 2013a).  
In our study, the revealed spectra resolution (reflected by mean water peak 
linewidths) was excellent within aMCC (0.0532 ppm) pIL (0.0513 ppm) and pIR 
(0.0514 ppm) but less within pgACC (0.0711 ppm). pgACC water peak linewidths 
were more than 25% broader compared to the other three regions. Similar 
observations have been reported by Dou et al. (2013), using an almost identical 
pgACC voxel positioning and size. We hypothesize that this concomitant 
observation might be attributed to interfering effects caused by arteria cerebri 
anterior (subcallosal artery) pulsation, clearly affecting the accurate shimming of 
the small pgACC voxel. Furthermore, varying frequency changes in local static 
magnetic field (B0) during spectral acquisition, mainly evoked by arterial 
pulsation, could additionally cause broadening of the peak linewidths (Hock et 
al., 2013b; Stagg and Rothman, 2013). In this context, techniques applied in 
spinal cord 1H-MRS – such as frequency alignment of single free induction 
decays before averaging, or cardiac triggering – can improve spectral resolution 
obtained from pgACC and other critically located brain areas (Hock et al., 2013a; 
Hock et al., 2013b). 
Generally, the good spectral quality resulted in low overall estimated fitting 
errors for the reported neurochemicals and regions. Mean CRLB were below 10% 
(thus lower than the typical consensus of 20%), although the fitting errors were 
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larger for insular cortex subregions (table 3). This dissimilarity is probably due to 
the smaller voxel sizes (3.04ml) and therefore slightly lower signal intensities 
compared to the cingulate subregions (3.46/4.14ml). Important to mention is 
that higher number of averages per region (although resulting in a longer 
acquisition time, which is not always feasible) results in increased SNR. This 
approach could compensate for signal drop accompanied by small voxel sizes 
thus lowering CRLB values. In this vein, to enhance spectral quality (and 
therefore reproducibility) it is favorable to combine small voxel dimensions and 
increased numbers of averages (instead of the usage of big voxels) to get both, 
narrow peak linewidths and high SNR (Kreis, 2004; Nacewicz et al., 2012). 
 
Intra-subject variability 
Results showed small intra-subject variation with mean CVs of 5.3% (aMCC), 
6.6% (pgACC), 7.3% (pIL) and 8.2% (pIR) over all reported neurochemicals, 
indicating robust within-subject measurement reproducibility. Intra-subject 
variability is a conglomerate of various variance sources. It can be influenced by 
the software quantification error, inaccurate voxel positioning/repositioning, 
individual biological variation between measurements (as daytime of 
participation) and head movement (Kreis, 2004; Stagg and Rothman, 2013). Thus 
considerable effort was put into controlling variance from the aforementioned 
factors. As a consequence, head movements were minute, variation of daytime 
of participation was acceptable. An ANCOVA with participants and region as fixed 
effects and GM/WM ratio, daytime of participation and head movements as 
covariates showed no significant explanatory contribution (by the covariates), 
confirming their rather negligible impact on the data. Otherwise, the fitting error 
(expressed as CRLB) seems to be a crucial source of intra-subject variance in our 
data demonstrated by a strong positive correlation (r = 0.799) between mean 
intra-subject CV and mean CRLB over all neurochemicals/regions. 
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An extreme example for the relationship between intra-subject CV and CRLB can 
be found in the dot-plot illustrating each single neurochemical concentration 
(Figure 3).  Focusing on the first two participants, obviously higher intra-subject 
variation of pIL mI concentrations compared to the other subjects is depicted. 
Analysis of fitting errors showed the highest CRLB exactly for these two subjects 
(subj. 1 [mean, range]: 13.5%, 9-20%); subj. 2: 10.5%, 7-16%; group average of 
subj. 3-9: 8%, 7-10%); corroborating our suggestion that CRLB mainly accounts 
for measured fluctuations in some neurochemicals/regions. We do not have a 
concise explanation for the outcome of these two participants as all assessed co-
variables were unobtrusive. 
 
Inter-subject variability 
Inter-subject variations with mean CVs of 9.05% (aMCC), 8.85% (pgACC), 10.00% 
(pIL) and 10.55% (pIR) were observed. Surprisingly, presented data indicate small 
differences between inter- and intra-subject CVs with mean CV-difference of 
2.75%. We think that the main reason for this observation is the homogeneous 
sample tested as all participants were male and between 20 and 30 years old. 
Previous studies showed significant age and gender effects on neurochemical 
concentrations (Grachev and Apkarian, 2000; Grachev and Apkarian, 2001; Haga 
et al., 2009), thus our approach in keeping age and gender within a tight range 
provides a probable explanation for the small differences in present data. This 
factor should generally be taken into account more rigorously in experimental 
settings, as effects can be attributed to age dependent alterations in 
neurochemical signatures rather than to the experimental variation itself 
(Gutzeit et al., 2013; Stagg and Rothman, 2013).  
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General discussion of the results within the literature context 
In principle, each 1H-MRS reproducibility study is inherently unique due to 
differences in applied MR scanner equipment and sequences, brain areas 
measured, number or participants tested, number of measurement sessions 
performed and the type of statistics finally reported. It is thus advisable to 
cautiously compare results across publications as no conclusive reproducibility 
criteria exist (Stagg and Rothman, 2013). Here, we opted to focus on studies 
investigating insular and cingulate cortex in order to remain within a comparable 
framework in terms of investigated brain areas. In this report, considerable effort 
was put into a correct anatomical classification of the regions of interest and the 
corresponding voxel positioning. Unfortunately, in neuroimaging studies, there is 
still no overarching rationale that supports identical basic definition regimes with 
respect to a distinct classification of cortical and subcortical subunits. This fact is 
reflected even in actual reports as rather imprecise anatomical descriptions are 
used (e.g. reported is "insula activity" despite the activity is clearly located in 
"anterior insula subdivision"). The importance of a correct sub-classification was 
demonstrated by a study conducted by (Gutzeit et al., 2013) showing significant 
differences in basic neurochemical concentrations between left and right 
lateralized anterior/posterior insular subdivisions. The differences were robust 
during acute dental pain stimulation, presumably reflecting inherent functional 
specificities of these insular subareas.  
With respect to the cingulate areas, our approach is based on extensive 
anatomical and cytoarchitectonic work (see introduction and methods section 
for all references incorporated). We consider that Dou et al. (2013) are partly in 
line with the presented anatomical definition, meaning that their investigated 
cingulate subareas, namely pgACC and aMCC, are almost identical to ours. Yet, 
the difficulty in comparing the works refers to the fact that they utilized ultra-
high fields at 7-Tesla and opted to calculate intraclass-correlations (ICC, instead 
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of coefficients of variation CV). This value represents a measure of reliability 
(instead of reproducibility) and therefore depends on population heterogeneity 
which makes it rather difficult to compare between studies (Müller and Büttner, 
1994; Henriques et al., 2013). It has to be clearly noted here that based on their 
reported ICC values they were able to reach high reliability values as well, 
however, reporting other neurochemicals as glutamine and GABA. Both 
components are tedious to detect without applying specific imaging regimes at 
3-Tesla. 
Venkatraman et al, (2006) estimated 1H-MRS reproducibility aspects in left and 
right anterior cingulate and hippocampus at 4-Tesla. Their voxel sizes were 6ml 
(compared to our 4.14ml), thus substantially larger. Based on the information 
provided (transversal section of voxel positioning scheme), it is not clear how 
specifically they defined their investigated cingulate subarea.  Interestingly, they 
revealed slightly higher intra-subject CVs compared with our results despite 
using larger voxels and higher field strengths (Mean CV (right/left hemisphere): 
tNAA = 10.0/7.2%; tCho = 12.8/9.1%; Cre = 9.5/6.6%; mI = 23.2/12.2%; Glu = 
11.8/14.1%; Glx = 17.4/13.3%). In addition to the different sequence parameters 
and water suppression scheme applied, differences in the CVs could be due to 
their used variability measure. Venkatraman et al. (2006) reported precision as a 
measure of reproducibility which was based on 10 repetitive measurements of 
the same subject (compared to our 9 subjects and 4 repetitive measurements. 
The differences in the CVs of Venkatraman et al. and our report could be further 
rooted in their broader linewidth of the right cingulate spectra (ca. 0.068 ppm 
(right hemisphere) vs our 0.0532 ppm), or that two different cingulate subareas 
were partly included, namely pgACC and aMCC. Due to variations in their 
cytoarchitectural structure, related neurochemistry might also differ what could 
be reflected in the differences reported by Venkatraman and colleagues.  
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Jang et al. (2005) did reproducibility analyses in the cingulate (similar to our 
pgACC-volume) and insular cortices using a 3T-scanner and voxel sizes of 4 ml. 
Contrary to the rationale of the present study, they did not separate between 
anterior and posterior segments of the insular cortex, thus, their results have to 
be compared to ours with caution. They revealed CV values for the inter-subject 
variability (tNAA (pgACC/Insula) = 8.7/9.4%; Cre = 7.6/11.4%; tCho = 11.8/13.1; 
mI = 13.8/15.9; Glu = 11.0/13.1; Glx = 7.2/11.2). Interestingly, despite applying 
larger insular cortex voxels, the characteristic reproducibility values were slightly 
higher than those of our study. It can only be speculated whether this fact results 
from not accounting for the cytoarchitectonic differences between 
anterior/posterior insular compartments or due to a more heterogenous study 
population. Considering the pgACC, their results indicate slightly lower inter-
subject variability which might be rooted either in the larger voxel (4 ml to 
3.46ml) or attributed to the fact that they measured the pgACC of each of the 21 
persons twice and averaged the intra-subj. data thus reducing the intra-subject 
variance component in the inter-subject variability measures. 
Altogether, bearing in mind differences in methodology and voxel definition, our 
work suggest comparable or slightly superior levels of variability in comparison 
to studies testing reproducibility of 1H-MRS in the cingulate and insular cortex 
(Jang et al., 2005; Venkatraman et al., 2006). These results are particularly 
remarkable regarding the applied voxel sizes which were used for neurochemical 
quantification in our regions of interest. Therefore, the present report suggests 
that pgACC, aMCC, pIL/pIR can well be targeted in clinical and scientific questions 
even using standard MR-equipment and 1H-MRS sequences at 3 Tesla. As 
pointed out in the introduction section, those areas play pivotal roles in a 
multitude of brain functions that are predominantly known from fMRI studies. In 
our opinion, 1H-MRS provides a complementary option by gaining information 
regarding neurochemical milieus. Knowing such baseline neurochemistry allows 
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for a more thorough understanding in both, healthy and disease conditions, as in 
the latter, neurochemical alterations are frequently reported. 
 
Limitations 
This report has limitations to consider. Beginning with our primary aim to assess 
spectra from anatomical/functional homogenous brain areas, we would like to 
emphasize existing differences across subjects' individual anatomy. The study 
sample consisted exclusively of 21-30 aged male participants. An adaptation of 
voxel dimensions may be necessary for the investigation of pgACC, aMCC pIL/pIR 
in female volunteers or populations with pathological brain conditions due to 
different brain sizes and pathology-rooted anatomical deviations. Thus, our 
results may not be generalizable to studies investigating such populations and 
further studies might be necessary. 
In the same vein, the narrow age range could represent a further limitation. 
Studies have shown that metabolite concentrations are subject to change over 
the life span (Haga et al., 2009). Our results may therefore not be generalizable 
to studies using a study sample with different age ranges or/and age groups due 
to differences in the magnitude of inter-subject variability. 
A clear limitation has to be allocated in possible movement influences especially 
when small areas are targeted. Although using a fixations system (Pearltec 
Crania) we additionally quantified head movements to estimate voxel 
displacement between the spectroscopic acquisitions only, hence, intra-
measurement movements were not accessible with this approach. However, the 
small peak linewidths combined with related minute variation indicate rather 
small movements during acquisitions, possibly related with the choice and 
positioning of the voxels clearly within the anatomical borders of the targeted 
brain subareas.  
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Conclusions 
Our study provides information regarding measurement reproducibility of the 
neurochemical milieu within strictly determined cingulate and insular subareas, 
namely:  pregenual anterior/anterior midcingulate as well and left and right 
posterior insular cortices. All areas were defined according to 
anatomical/cytoarchitectonic work to guarantee the best possible within region 
homogeneity as well as an optimal agreement according to their functional 
specificity. It can be concluded, that the reported neurochemicals are reliably 
measurable in those areas as reflected in small intra/inter subject variations. We 
therefore think that based on the presented rationale, it is possible to conduct 
1H-MRS studies in small and functional homogenous – and often critically 
located – brain areas. When applied with the necessary diligence, we think that 
profound insights of the neurochemical status in both, health and disease can be 
obtained, possibly even on single-subject level.  
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5.2.1 Abstract 
The trigeminal brainstem sensory nuclear complex is the first central relay 
structure mediating orofacial somatosensory and nociceptive perception. Animal 
studies suggest a substantial involvement of neurochemical alterations at such 
basal CNS levels in acute and chronic pain processing.  Translating this animal 
based knowledge to humans is challenging. Human related examining of 
brainstem functions are challenged by MR related peculiarities as well as 
applicability aspects of experimentally standardized paradigms.  
Based on our experience with an MR compatible human orofacial pain model, 
the aims of the present study were twofold: 1) from a technical perspective, the 
evaluation of proton magnetic resonance spectroscopy at 3 Tesla regarding 
measurement accuracy of neurochemical profiles in this small brainstem nuclear 
complex and 2) the examination of possible neurochemical alterations induced 
by an experimental orofacial pain model.  
Data from 13 healthy volunteers aged 19 to 46 years were analyzed and revealed 
high quality spectra with significant reductions in total N-acetylaspartate (N-
acetylaspartate + N-acetylaspartylglutamate) (-3.7%, p = 0.009) and GABA (-
10.88%, p = 0.041) during the pain condition. These results might reflect 
contributions of N-acetylaspartate and N-acetylaspartylglutamate in neuronal 
activity-dependent physiologic processes and/or excitatory neurotransmission, 
whereas changes in GABA might indicate towards a reduction in tonic GABAergic 
functioning during nociceptive signaling.  
Summarized, the present study indicates the applicability of 1H-MRS to obtain 
neurochemical dynamics within the human trigeminal brainstem sensory nuclear 
complex. Further developments are needed to pave the way towards bridging 
important animal based knowledge with human research to understand the 
neurochemistry of orofacial nociception and pain. 
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5.2.2 Introduction 
Pain in general and orofacial pain in particular are complex multifaceted 
phenomena encompassing sensory, affective, cognitive and motor processes. 
Worldwide costs, suffering and psychosocial distress especially in chronic forms 
are immense (Maixner et al., 2011; Murray and Lopez, 2013). Related brain 
mechanisms have been disentangled up to a certain degree, with several 
(predominantly cortical) areas being involved in decoding specified information 
from the underlying pain cascade (Peyron et al., 2000; Wager et al., 2013; Denk 
et al., 2014). In contrast to these quite well described (pain related) neuronal 
correlates, the brainstem still remains scarcely characterized, particularly in 
humans (Beissner and Baudrexel, 2014).  
As neuronal gate to and from the cortex, this structure is involved in a multitude 
of vital functional processes and of crucial importance for our daily survival. The 
functional spectrum of this area covers co-control of breathing, sleep-wake 
rhythms, blood pressure, heart rate, pain modulation and even higher cognitive 
and psychological functions (Sessle, 2005; Fairhurst et al., 2007; Hurley et al., 
2010). 
Listed as one of the most prevalent pain conditions, orofacial pain seems 
strongly associated with maladaptive brainstem processing (Sessle, 2000; 
Maixner et al., 2011). The collective term “orofacial pain” encompasses a variety 
of pain types perceived in the face, jaw and oral cavity including acute (eg. dental 
pain) and chronic conditions (eg. trigeminal neuralgia; trigeminal neuropathic 
pain; burning mouth syndrome; temporomandibular disorders) (Zakrzewska, 
2013). One commonality of these different pain types is that their nociceptive 
information is exclusively transmitted to the brain via the trigeminal brainstem 
sensory nuclear complex (TBSNC) (Sessle, 2000). This intricate nuclear cluster 
represents the first relay station in the brain for peripheral somatosensory 
afferents from the trigeminal nerve (and to a smaller extent from the facial and 
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glossopharyngeal nerves) (Sessle, 2000; DaSilva and DosSantos, 2012). It consists 
of three nuclei ranging from the mesencephalon down to the cervical dorsal 
horn, namely: mesencephalic, principal and spinal trigeminal nucleus 
(Nieuwenhuys et al., 2008). The spinal trigeminal nucleus (Sp5) is further 
subdivided into three subnuclei in a rostral to caudal fashion: Subnuclei pars 
oralis, pars interpolaris and pars caudalis (Dubner and Bennett, 1983; Beck et al., 
1997; Nieuwenhuys et al., 2008). The TBSNC (Sp5 in particular) receives 
nociceptive signals from the ipsilateral site of the face and mouth via Aδ and C-
fibers and forwards them via 2nd-order neurons to the contralateral ventral 
posteromedial nucleus (VPM) of the thalamus from which the stimuli are further 
projected to several cortical structures (Nieuwenhuys et al., 2008). 
Based on animal studies, cellular and neurochemical alterations in the TBSNC 
were suggested being crucially involved in processing acute pain as well as in 
maladaptation mechanisms leading to pain chronification. Neurochemicals 
released in the TBSNC by afferents, interneurons and (pain) modulatory 
pathways – most notably GABA, 5-HT and opioids – alter the processing of 
nociceptive input on that basal CNS level (Sessle, 2000). Exemplary are various 
investigations demonstrating changes in GABAergic neurotransmission 
associated with trauma, inflammation and partial deafferentation (Sessle, 2000; 
Viggiano et al., 2004; Takeda et al., 2011). Additionally, evidence is given by 
chronic neuropathic pain models. Using a constriction injury model of the rat 
infraorbital branch of the trigeminal nerve (CCI-ION), only baclofen (a GABAB-
receptor agonist) but not carbamazepine, morphine or tricyclic antidepressants 
were able to reduce the allodynia-like behavior (Idänpään-Heikkilä and Guilbaud, 
1999).  Using a similar model, Martin et al. (2010) found a decrease in GAD65 
immunoreactivity in the caudal nucleus of the Sp5 suggesting a disruption in 
GABA-mediated inhibitory circuits.  
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Few human neuroimaging studies addressed the specific functional/anatomical 
contributions of the TBSNC in acute and chronic orofacial pain by applying 
functional magnetic resonance imaging (fMRI) (DaSilva et al., 2002), diffusion 
tensor imaging (DTI) and voxel-based morphometry (VBM) (Wilcox et al., 2015). 
However, none of the performed neuroimaging studies provided insights 
regarding neurochemical alterations in the human TBSNC thus corroborating 
some results provided by animal studies. But this question could be addressed by 
proton magnetic resonance spectroscopy (1H-MRS), a powerful method able to 
simultaneously quantify neurochemical compounds in a defined brain region. 
Typically measured neurochemicals provide for example information about 
neuronal density and viability (N-acetylaspartate), energy metabolism 
(creatine/phosphocreatine), membrane turnover and integrity (choline), 
antioxidant status (glutathione), glial cell proliferation (Myo-inositol) or 
neurotransmission (Glutamate, GABA, N-acetyl-aspartyl-glutamate)(Stagg, 2013). 
Theoretically, 1H-MRS allows observing neurochemical processes and alterations 
associated with acute and chronic (orofacial) pain conditions within relevant 
brainstem nuclei. Thus a bridge from human research to the animal studies on 
TBSNC might be in reach.  
However, in-vivo measurements on brainstem levels face a series of significant 
challenges as technical, structural and physiological characteristics of the 
brainstem and spinal cord impede proper MR acquisitions. Blood flow in adjacent 
arteries/venes and CSF pulsation in and around the brainstem induce 
inhomogeneity in the static magnetic field (B0) thus causing frequency shifts 
resulting in poor spectral resolution (Brooks et al., 2013; Beissner and Baudrexel, 
2014; Hock et al., 2013). Furthermore, the signal obtained by 1H-MRS is in 
general very minute, demanding large measurement volumes (usually voxel sizes 
of 8 ml) in order to achieve sufficient signal-to-noise ratios (SNR) in a reasonable 
acquisition time (Kreis, 2004; de Matos et al., 2016). But, measuring the TBSNC 
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with the adequate anatomical and functional specificity demands smaller voxel 
sizes and hence requires adaptations towards long acquisition times. Those, in 
turn enhance the likelihood for temporal changes in the B0 field caused by 
subject motion and B0 drifts resulting in frequency and phase shifts between 
single free induction decays (FIDs). All these facets hamper spectral quality 
aspects and require careful planning and adequate measurement strategies 
(Hock et al., 2013c).  
In this feasibility study, we provide a brainstem optimized 1H-MRS sequence and 
data post processing scheme in combination with a reliable experimental dental 
pain model in healthy volunteers. The following two questions were pursued: 1) 
1H-MRS measurability aspects of a small brainstem area from a technical 
perspective and 2) possible alterations in the neurochemical milieu induced by 
experimental dental pain. 
5.2.3 Materials and Methods 
The present study was conducted from March 2015 to December 2015 according 
to the Declaration of Helsinki and was approved by the local ethics committee.  
 
Subjects 
26 healthy males (mean age: 27.35 ± 6.84, range: 19-46) were recruited for the 
study. Inclusion criteria required the test tooth (right upper canine) to be vital, 
caries free, sensorically intact and free of previous dental treatments. Exclusion 
criteria were psychiatric and neurologic diseases, regular pain medication intake, 
pain syndromes, claustrophobia and general contra-indications for MR. No 
female volunteers were recruited due to possible variability in pain perception 
caused by menstrual cycle associated variation in hormonal levels (Wiesenfeld-
Hallin, 2005).  
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All subjects received detailed information about the experimental procedure, 
aim of the study and provided their written informed consent before any 
procedure was performed. Subjects were instructed not to consume alcohol, 
analgesic medication and other drugs 24h before the start of the MR experiment 
and to be fed before participation. Participants were explicitly informed to have 
the possibility to terminate participation and withdraw from the study at any 
time. They were financially compensated (40 Swiss francs/hour) for the effective 
time of participation.  
From the initial 26 recruited participants, 8 were excluded after the test session 
due to insufficient and/or inconstant pain intensity perception; therefore 18 
subjects were included in the study. Two subjects had to be excluded due to 
spectral artifacts and two others due to insufficient spectral resolution (FWHM 
NAA > 10Hz). An additional subject had to be excluded due to strong movements 
during the experimental conditions, resulting in a total of 13 (mean age: 27.69 ± 
7.89, range: 19-46) data sets for analysis.  
 
Dental Stimulation Setup 
Dental stimulation was administered to the right upper canine. For this purpose, 
individual dental splints with non-ferromagnetic stainless steel electrodes 
embedded directly at the center of labial and palatal surfaces were fabricated. 
To reduce electrical resistance, small portions of hydrogel (size ca. 3x3mm) 
covering the electrodes were applied before splint insertion.  
In addition to the tooth stimulating electrodes, a small 2 MΩ resistor (surface-
mount device, SMD, KOA Corporation, Tokyo, Japan) was placed on the left side 
of the dental splint over the second left incisor tooth and sealed with Blu-
Mousse (thixotropic vinyl polysiloxane; Parkell, Edgewood, USA). This resistor 
served as “dummy tooth” enabling running of the stimulation procedure during 
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the baseline measurements without evoking sensory perceptions. This approach 
allowed for identical conditions during baseline and pain 1H-MRS measurements. 
For details regarding splint fabrication and stimulation equipment specs, please 
see Gutzeit et al., 2013. 
 
Psychophysical testing and familiarization 
Subjects were invited to a test session 1-2 weeks prior to the MR-experiment. 
The aim of this preceding visit was fourfold: 1) Check of inclusion/exclusion 
criteria, 2) manufacturing of the dental splint, 3) psychophysical testing of the 
subjects’ sensory and pain thresholds and 4) familiarization of the participant 
with the dental stimulation procedure and equipment. 
The psychophysical testing consisted of the administration of electrical pulses of 
1 ms duration with linearly increasing electrical currents and randomized inter-
stimulus-intervals (ISI) 5-8s long. The procedure started at an imperceptible 
intensity of 1 mA; the intensity was then increased in steps of 1 mA. Thresholds 
for sensory detection (SDT), pain detection (PDT), and a stimulus intensity 
corresponding to the subjects’ individual rating of 4-5 (moderately painful) on a 
NRS were obtained. 4-5 was the target pain intensity for the pain stimulation 
condition in the MR-experiment. Subjects indicated the SDT, PDT and 4-5 by 
hand signs. This procedure was repeated 3 times to assure the stability of 
individual sensory thresholds as well as account for novelty effects and potential 
initial feelings of uneasiness associated with the dental stimulation.  
 
Experimental Procedure  
At the beginning of the MR-experiment, psychophysical testing (procedure 
identical to the test session) was performed and the SDT, PDT and intensity of 4-
5 was evaluated outside the scanner to test the participants’ current perceptual 
characteristics. 
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The subjects were then positioned in the 3-Tesla MR unit (Philips Healthcare, 
Best, The Netherlands) in a supine position. Since small voxel dimensions were 
applied in an anatomical localization difficult to investigate, it was crucial to keep 
head movements at a minimum. Multipad positioning cushions (Pearltec AG, 
Schlieren / Zurich, Switzerland) were used for this purpose. Two were bilaterally 
placed between the temple and the coil, and a third was positioned under the 
participant’s neck/occipital head. Subjects adjusted the cushion inflation for 
optimal comfort which is essential considering the extended measurement 
durations. Participants were instructed to press the alarm button in case of 
discomfort caused by the head fixation system.  
After acquisition of anatomical sequences and placement of the MRS-voxel, the 
baseline MRS measurement was obtained. During this baseline condition, 
dummy stimulation was applied. Psychophysical testing was then repeated inside 
the scanner to adjust, if necessary, the electrical current strength evoking a 4-
5/10 pain intensity. Prior to the painful measurement sequence, correct voxel 
placement was verified on another set of anatomical images and adjusted if 
necessary. Electrical stimulation during the baseline and pain stimulation block 
consisted of 128 short pulses (1 ms, identical characteristics as during the 
psychophysical testing) administered with an ISI of 10-12.5s (block duration: 
approx. 21 minutes). Previous work demonstrates that the applied dental 
stimulation paradigm is not prone to sensitization and habituation effects during 
long measurement periods (Brügger et al., 2012). The total duration of the MR 
measurement was approx. 60 min. 
 
MR protocol 
The integrated body coil was used for transmission (maximum B1 = 13.5 μT); a 
receive-only 8 channel head coil array (Philips Healthcare, Best, NL) was applied 
for signal reception. Anatomical high-resolution T2-weighted turbo spin-echo 
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sequences were performed in axial and sagittal orientations (TR/TE = 3000/120; 
Flip-angle = 90°; voxel size 0.8x1x3.2mm3) to ensure precise voxel planning and 
positioning. 
For the MR spectra acquisition, an inner-volume saturated (IVS)(Edden et al., 
2006; Hock et al., 2013), non-water suppressed PRESS (point-resolved 
spectroscopy) sequence (TR/TE = 2500/32 ms; data points = 1024; sample 
frequency = 2000 Hz; readout duration = 512 ms; number of averages = 512) was 
used via the metabolite cycling (MC) technique (MC-PRESS) (Dreher and Leibfritz,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Panels A-C illustrate the MRS voxel placement on sagittal (A), coronal (B) and 
transversal (C) anatomical images. Orange and white boxes represent the acquisition volumes of 
lactate (orange) and myo-inositol (white) which are shifted relative to each other due to the 
chemical shift artifact. This artifact is reduced by the use of inner-volume saturation (IVS) bands. 
The red box corresponds to the resulting excitation volume generating the MRS signal. In 
addition, the shim box is represented by the green box. Panels D-F illustrate the position of the 
excitation volume (red) in relation to the schematically represented TBSNC with the associated 
mesencephalic (dark green), primary (light green) and spinal trigeminal nuclei (blue) on sagittal, 
coronal and transversal images.  
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2005; Hock et al., 2013). This  enables a simultaneous recording of water and 
neurochemical signals, by adding or subtracting consecutively acquired echoes 
modulated via alternate up- or downfield inversion pulses which do not affect 
the water signal (Dreher and Leibfritz, 2005; Hock et al., 2013). Therefore, MC-
PRESS allows the acquisition of high SNR water-peaks from single FIDs, 
permitting frequency alignment, phase and eddy current correction before 
averaging of neurochemical spectra. Hence, MC-PRESS provides the potential to 
reduce frequency shifts caused by pulsatile effects of blood vessels/CSF and B0  
drifts. Furthermore, the simultaneous acquisition of both water and 
neurochemical signals means that both are subject to the same MR-specific and 
physiologic influences thus optimizing the use of the water peak as an internal 
reference during neurochemical quantification.  
To optimally cover the region of interest, the MRS voxel was carefully placed 
along the transition zone to the 4th ventricle. Important to note: due to 
individual shapes and contours of the volunteers’ brainstem, the placements 
were adjusted to avoid contamination of the MRS voxel with CSF from the 4th 
ventricle, central canal and cisterna magna. The voxel was placed on the 
ipsilateral side in reference to the stimulated tooth using following dimensions: 
37.6 x 8.5 x 7.6 mm (2.4ml, Fig. 1).  
 
MRS data post processing 
MRS data were post-processed according to Hock et al. (2013; 2016). The 
individual 512 FIDs were truncated after 100ms and zero-filled to 1024 points, 
followed by frequency alignment, phase and eddy current correction of 
individual FIDs before averaging. These steps were performed using in-house 
scripts running on MATLAB 2013b (MathWorks, Natick, MA, USA).  
In case of a significant mismatch of spectral linewidth estimates between both 
conditions, filtering by means of an exponential multiplication was performed to  
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minimize systematic errors in neurochemical quantification. This approach 
prevents false neurochemical differences between the conditions (Mangia et al., 
2007). The correction was done by matching the water peak linewidth to the 
water peak linewidth of the pain spectrum. Individual filter parameters were 
chosen to ensure the best match possible for each participant.  
 
Quantification of Neurochemicals 
 Neurochemicals were quantified with LCModel (Provencher, 1993) using a set of 
basis spectra which were simulated using the GAMMA Simulation Package 
(Smith et al., 1994). The basis set included the following components: N-acetyl 
Figure 2: Exemplary spectrum fitted with LCModel. The fitted spectum (red) is superimposed on 
the raw spectrum (grey). The difference of raw and fitted spectrum is displayed by the residuum 
which is an indicator for the goodness-of-fit. The spectral baseline is delineated by the dashed 
grey line. The fits of the reported neurochemicals are displayed below the baseline. 
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aspartate (NAA), N-acetyl-aspartyl glutamate (NAAG), glycerophosphocholine 
(GPC), phosphocholine (PCh), creatine (Cre), myo-Inositol (mI), glycine (gly), 
alanine (Ala), ascorbic acid (Asc), aspartate (Asp), ethanolamine and 
phosphorylethanolamine (PE), glutamine (Gln), glutamate (Glu),  
glutathione (GSH), glucose (Glc), γ-aminobutyric acid (GABA), lactate (Lac), 
taurine (Tau) and scyllo-inositol (sI). The chemical shift range was set to 4.0-0.5 
ppm. Following neurochemicals with strongly overlapping spectra were 
combined to one single spectrum: Glu + Gln = Glx, GPC + PCh = tCho, mI + Gly = 
tmI and NAA + NAAG = tNAA.  
With respect to neurochemical related inclusion criteria, we followed the 
suggestions provided by De Graaf (2007): Neurochemicals with CRLB<10% count 
as measured with sufficient precision, neurochemicals with CRLB <20-30% should 
be considered with caution whereas neurochemicals with CRLB >30% are 
deemed unreliable and should therefore be excluded from the analysis. Hence, 
the following neurochemicals were included: tNAA, tCho, tmI, Cre, Glx, GSH, 
Scyllo and GABA.  
We decided to use water (from the simultaneously acquired water spectra) as 
internal reference instead of Cre due to the following reasons: 
1. Previous pain MRS studies observed significant alterations in Cre 
concentrations (see Gutzeit et al., 2013). 
2. Reduced sensitivity due to combined quantification errors of Cre and the other 
neurochemicals (resulting in higher variation). 
3. Unspecific Cre signal changes could either under- or overestimate "true" 
effects in other neurochemicals evoked by the experimental conditions.  
 
Movement  
Two navigator sequences were performed during both conditions. This 
procedure enables two different approaches to reduce the impact of motion on  
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the neurochemical data: Firstly, real time feedback to instruct the volunteers not 
to move and secondly, rejecting data sets with excessive levels of motion.  
0.511.522.533.54 0.511.522.533.54
chemical shift [ppm]
0.511.522.533.54
Baseline
0.511.522.533.54
Pain
A B
C D
Figure 3: Overview of the spectral quality range of included spectra. Quality estimates (from 
LCModel) of the best spectrum (A) were: SNR = 23, Linewidth = 4.85 Hz. Estimates of the worst 
(B) were: SNR = 12, Linewidth = 7.79 Hz. Mean spectral quality over all spectra: SNR = 19.08, 
Linewidth = 6.41 Hz. Panels C and D illustrate the spectral variability as overlay of all 13 included 
spectra (colored lines) with the corresponding averaged spectrum (black) for the baseline (C) and 
pain (D) condition. 
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Navigator sequences were carried out in the dead time before the inner-volume 
saturation (IVS) pulses of each single MRS acquisition (pencil-beam excitation 
with radius r = 30mm and length l = 100mm; flip-angle = 15°, acquisition duration 
= 2.9ms) (Hock and Henning, 2016).  
The first navigator (Nav I, anterior-posterior axis) was positioned ventral to the 
MRS voxel perpendicularly oriented to the medulla. The second one (Nav II, left-
right axis) was placed dorsally to the MRS-voxel covering corpus callosum and 
occipital areas (Fig. 4).   
Navigator positions were extracted from the raw MR data using MRecon 
(GyroTools, Zurich, Switzerland). The extracted movement data was used for the 
calculation of relative movement during individual scans using the first navigator 
acquisition as reference. A gating window of ±1mm was used to identify echoes 
associated with significant movement. Navigator data demonstrating excessive 
noise were excluded (See excluded data sets in supplementary material).  
Figure 4: Placement of the two navigators (orange) shown on sagittal (A) and coronal (B) images. 
The lower navigator (Nav I) measured movement in the anterior-posterior axis, he upper 
navigator (Nav II) measured movement in the left-right axis. The red box corresponds to the MRS 
excitation volume.  
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Spectra from individual participants were excluded from the analysis based on 
their movement estimates if more than 10% of the individual spectral 
acquisitions were shifted outside the gating window. 
 
Statistical analysis 
SPSS 22 (IBM Corp., Armonk, NY, USA) was used to perform the statistics; the 
significance threshold was set at p < 0.05. First, data were tested for normal 
distribution by means of the Shapiro-Wilk test. Differences between both 
experimental conditions regarding neurochemical concentrations were tested 
using a paired t-test, whereas comparison of SNR and linewidth was tested using 
a Wilcoxon signed-rank. In order to estimate reproducibility, inter-scan variability 
(variability between baseline and pain condition for each participant) was 
estimated by means of coefficient of variation (CV, calculated as SD/Mean*100). 
 
5.2.4 Results 
 
Data quality 
Mean spectral quality and fitting error estimates for both conditions are shown 
in table 1.Linewidth estimates provided by LCModel differed significantly 
between both conditions (Z = -2.670, p = 0.008). In order to minimize linewidth 
differences, individual baseline spectra were filtered resulting in negligible 
linewidth differences (Z = -0.509, p = 0.611). 
Mean SNR was 19.1 for both conditions and thus not significant (Z = 0.000, p = 
1.000). 
The good data quality is also reflected by the low CRLB over all spectra and all 
subjects (Baseline: 9.6%; Pain: 11.1%). As a consequence, resulting inter-scan CV  
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were low with mean CV of 9.85% over all participants and included 
neurochemicals (see Table 1).  
 
Movement 
Two movement datasets from navigator 2 had to be excluded due to excessive 
noise, resulting in a complete data set of 13 movement profiles for navigator 1 
(anterior-posterior, AP) and 11 movement profiles for navigator 2 (left-right, LR; 
Illustrations of the individual movement profiles are provided in the  
supplementary material). Spectra from one participant had to be excluded due 
to a significant drift movement in the anterior-posterior direction.  
The movement quantification results are summarized in table 3. The overall 
movement was negligible with mean displacements of -0.22 mm (AP) and -0.25 
(LR). Accordingly, the percentages of navigator echoes exceeding displacements 
of ±1mm were minute with mean percentages of 0.70% (AP) axis and 0.81% (LR). 
No significant differences were observed in mean displacement magnitudes 
between baseline and pain conditions for Nav I (Z = 0.52, p = 0.60) and Nav II (Z = 
0.80, p = 0.42). In the same vein, the count of single navigator echoes lying  
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outside gating window were also not significant between the baseline and pain 
condition for both navigators (Nav I: Z = -0.60, p = 0.55; Nav II: Z = 0.00, p = 1.00).  
 
Neurochemical concentrations: 
Table 2 shows absolute neurochemical concentrations and the resulting changes 
with corresponding paired t-test results. Figure 2 graphically illustrates the intra-
individual neurochemical differences as boxplots. tNAA and GABA revealed 
significant alterations during the pain condition. tNAA showed the most 
significant differences with a consistent drop during pain (T = 3.130(12); p = 
0.009). Also GABA demonstrated a significant concentration drop during pain (T 
= 2.286(12); p = 0.041).  
 
5.2.5 Discussion 
In the present study, neurochemical changes within the human TBSNC during 
experimental orofacial pain were assessed by brainstem-optimized functional 1H-
MRS. To our knowledge, this is the first human study which quantified 
neurochemical alterations at anatomically distinct brainstem level in response to 
experimental nociception. The combination of MC-PRESS 1H-MRS-sequences and 
dedicated spectral post-processing enabled the acquisition of high quality 
spectra in spite of the present technical challenges inherent to the brainstem, 
long measurement times and small voxel dimensions. Eight neurochemicals were 
quantified with good reproducibility as indicated by overall low CRLBs and inter-
scan CV (Table 1).  
From these eight neurochemicals, significant decreases were observed for tNAA 
and GABA during the pain application. 
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Mechanisms underlying NAA and NAAG decreases with an emphasis on 
nociception 
NAA is one of the most abundant neurochemicals in the human nervous system 
reaching high concentrations of approx. 10mM (Moffett et al., 2007). In 1H-MRS, 
this neurochemical is typically represented by the highest peak in the spectrum 
which originates from three nearly equivalent methyl hydrogen atoms on the 
acetate group resonating with a frequency shift of 2.02 ppm relative to the MRS 
standard tetramethylsilane (De Graaf, 2007). NAA is specific to neurons, being 
predominantly synthesized in neuronal mitochondria from aspartate and acetyl-
coenzyme A by the enzyme L-aspartate N-acetyltransferase (Asp-NAT) (Stagg, 
2013). NAA synthesis has been shown to be coupled to oxygen consumption and 
adenosine triphosphate (ATP) production, thus linking NAA to mitochondrial 
activity and associated neuronal energy metabolism (Benarroch, 2008).  NAA 
Figure 5: Boxplots of the percent changes in neurochemical concentrations between baseline 
and pain condition. tNAA and GABA showed a statistically significant reduction during pain 
stimulation. *p<0.05; **p<0.01 
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counts as a reliable marker of neuronal health and integrity (Rae, 2014).  
Pursuant to, a variety of clinical conditions demonstrate transient or permanent 
decreases, confirmed in stroke, Alzheimer’s disease, epilepsy, brain tumors, 
multiple sclerosis, schizophrenia, chronic low back and orofacial pain  (Moffett et 
al., 2007; Benarroch, 2008; Gussew et al., 2011; Gustin et al., 2011). These 
results point towards an indubitably important role of NAA in those pathological 
conditions. However, it should be emphasized that its utility as marker for 
general neuronal health is primarily based on empirical evidence and not on a 
profound understanding of its specific neuronal functions, in particular during 
neuronal activity (Moffett et al., 2007; Stagg, 2013; Rae, 2014). 
A variety of functional roles of NAA have been suggested in animal and human 
research. Baslow and coworkers (Baslow, 2002; Baslow et al., 2007; Baslow et al., 
2016) proposed that NAA might additionally function as molecular water pump 
(MWP), able of removing excess water produced by increased glucose 
respiration during neuronal activation. According to this hypothesis, NAA is 
actively transported to the extracellular space in conjuction with bound water 
molecules. Subsequently, NAA is catabolized by aspartoacyclase (ASPA) in 
oligodendrocytes, releasing the bound water molecules and thus allowing water 
removal from the extracellular space by astrocytes. Although intriguing, the 
MWP-theory remains hypothetical as to date no key transport protein has been 
identified. Another possible mechanism for a controlled release of NAA during 
neuronal activation has been suggested by experiments performed on 
organotypic hippocampal slices. Tranberg et al. (2004) observed a NAA release 
during a 20 min period after a transient 5 min activation of NMDA-receptors. 
Importantly, the NAA efflux was not due to potassium depolarization, but to a 
NMDA-mediated influx of Ca2+.  
Such NMDA-mediated releases of NAA could function as an activity-driven 
mechanism for metabolic water removal thus supporting neurophysiological 
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processes proposed by Baslow et al. (Baslow, 2002). In addition, this NMDA-
mediated release could constitute a regulation mechanism for axon-glial 
signaling, which has been proposed by others (Moffett et al., 2007). 
Widely accepted is the role of NAA as precursor for N-acetylaspartylglutamate 
(NAAG), the highest concentrated neuropeptide in the human CNS (Benarroch, 
2008). NAAG is synthesized in neurons from NAA and glutamate and is then 
synaptically (calcium mediated) released. NAAG is predominately converted by 
glutamate carboxypeptidase II (GCPII) located on the surface of astrocytes. GPCII 
hydrolyzes NAAG back to NAA and glutamate which are taken up by astrocytes. 
Glutamate is then converted to glutamine and transported back to neurons. 
NAA, however, is most likely released to the blood stream by astrocytes (Moffett 
et al., 2007).  
It has been suggested that NAAG binds to the metabotropic glutamate receptor 
3 (mGluR3) located on presynaptic endings thus enabling a modulation of 
neurotransmitter release (Zhao et al., 2001; Zhong et al., 2006). Due to the co-
localization of NAAG with major neurotransmitters (including glutamate, GABA, 
acetylcholine and serotonin, dopamine and norepinephrine), it possibly 
modulates their release from synapses (Moffett et al., 2007). It has been further 
proposed that NAAG could function as modulatory pro-transmitter. In this view, 
NAAG would act as a glutamate carrier, releasing glutamate at sites where active 
GCPII enzymes are present, therefore promoting focal glutamatergic 
neurotransmission (Stagg, 2013).  
Functional 1H-MRS (fMRS) studies have been conducted in the past to investigate 
neurochemical dynamics of acute experimental pain processing in cortical 
regions (anterior/posterior insular cortex, pregenual anterior cingulate cortex) of 
healthy volunteers (Mullins et al., 2005; Kupers et al., 2009; Gussew et al., 2010; 
Gutzeit et al., 2011; Gutzeit et al., 2013). Indeed, none of the performed studies 
reported significant changes in tNAA. Most interestingly, Gutzeit et al. (2011, 
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2013) applied the identical stimulation paradigm to investigate acute dental pain 
processing in the insular cortex and neither observed significant alteration 
regarding tNAA.  
What could be possible reasons for the discrepancy between the presented work 
and previous fMRS pain studies? On one hand, the TBSNC represents the first 
CNS relay area, processing "pure" somatosensory input, thus reflecting basic 
nociception in contrast to multifaceted "pain" processing in cortical regions. And 
with respect to brainstem neurochemical characteristics and compositions, 
various features are evident compared to cortical regions, especially regarding 
NAA and NAAG. Based on animal studies it has been stated that Asp-NAT enzyme 
activity increases from rostral to caudal brain structures with brainstem and 
spinal cord exhibiting the highest activity levels (Truckenmiller et al., 1985; 
Moffett et al., 2007). Interestingly, the expression of NAAG has been suggested 
to follow an analogue rostral-to-caudal pattern, being present at highest 
concentrations in the brainstem and spinal cord (Moffett and Namboodiri, 2006; 
Lodder-Gadaczek et al., 2011). Considering the reports on the absence of a 
similar concentration gradient of NAA (Tallan, 1957; Miyake et al., 1981), the 
elevated levels of NAAG may be linked to higher NAA synthesis rates in 
brainstem structures. In parallel to high NAAG concentrations, high densities of 
GCPII enzymes and mGluR2/3 were documented for the Sp5 in animal 
immunocytochemistry studies (Slusher et al., 1992; Tang et al., 2001), both 
closely interacting with NAAG  (Zhao et al., 2001; Zhong et al., 2006). Under the 
consideration of suggested interactions between GCPII and neuropathic pain 
(Zhang et al., 2002; Zhang et al., 2006; Yamada et al., 2012) and mGlu2/3 
receptors involved in orofacial pain at brainstem levels (Tang et al., 2001), our 
results provide evidence regarding NAAG release and catabolism in acute 
nociceptive pain processing in the human TBSNC. 
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Altogether, the observed tNAA reduction during the pain condition may reflect 
enhanced nociceptive-related NAAG neurotransmission in the TBSNC. The 
released NAAG would be degraded by GCPII releasing glutamate and NAA. The 
subsequent removal of NAA would finally result in a reduction of NAA signals in 
the spectrum. Hence, such a nociception/pain associated involvement of NAAG 
in the TBSNC could result in the observed reductions of tNAA. Furthermore, as 
NMDA likely plays a major role in nociceptive processing within the TBSNC 
(Sessle, 2000), activated NMDA receptors (either by direct glutamate release or 
indirect via NAAG) possibly lead to NAA efflux, thus further reducing the 
observable amount of NAA in the MRS signal.  
 
Mechanisms underlying GABA decreases with an emphasis on nociception 
GABA has two main roles within the CNS: On one side, it acts as neuronal 
metabolite throughout the cytoplasm and reflects the largest pool of GABA 
(Stagg, 2013). On the other hand, it is best known as main inhibitory 
neurotransmitter in the CNS (Stagg et al., 2011a). It binds to two main types of 
receptors, both widely distributed over the brain, namely the ionotropic 
receptors GABAA and metabotropic GABAB. They are located pre/post and 
extrasynaptically, hence underlying its comprising role to extensively alter neural 
activation (Rae, 2014). GABA is thus involved in the modulation of a variety of 
physiological processes (motor control, pain, sleep) and is supposed to be 
dysfunctional in several pathological conditions (epilepsy, anxiety, wake-sleep 
disturbances, schizophrenia) as well as developmental and neurodegenerative 
disorders (Rae, 2014). 
However, to describe distinct roles of GABA within this functional diversity is 
challenging.  Exemplary is the study of Jasmin et al. (2003). By selectively 
modulating GABAergic mechanisms within a distinct posterior insula subarea of 
freely moving rats, they evoked either analgesia by general GABAergic mediated 
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down regulation via brainstem areas or hyperalgesia by specific GABAB receptor 
mediated amygdala projections. In this vein, further evidence is given by studies 
examining the link between animal (chronic) orofacial pain models and GABA 
alterations in the TBSNC, indicating generally reduced GABA levels within these 
pathological conditions (Idänpään-Heikkilä and Guilbaud, 1999, Sessle, 2000; 
Takemura et al., 2001; Viggiano et al., 2004; Martin et al., 2010; Takeda et al., 
2011). Also, a recent animal study by François et al. (2017) proposed a crucial 
role of GABAergic neurons, however, within the rostral ventromedial medulla 
(RVM) in integrating sensory inputs together with internal state information, 
which finally leads to a gatekeeper function for mechanically evoked pain. They 
further suggest "that multiple parallel GABAergic systems may exist for 
independent descending control of distinct somatosensory modalities". 
In addition to evidence provided by animal research, human resting-state and 
functional 1H-MRS studies suggest GABA involvement in clinical and acute 
experimental pain conditions. Henderson et al. (2013) examined GABA resting-
state concentrations in the thalamus of patients with painful trigeminal 
neuropathy (PTN, a form of chronic orofacial pain) compared to healthy 
volunteers and found significant GABA decreases in patients only. Additionally, 
they measured volumetric gray matter reductions in the thalamus of PTN 
patients but not in controls. In our opinion, a conclusive interpretation of their 
findings as either chronic pain related down-regulated GABAergic 
neurotransmission or neuronal loss including GABAergic neurons is challenging 
and needs further investigation. More closely related to our study is the 
experiment performed by Cleve et al. (2015). Experimental thermal pain was 
administered to healthy volunteers and GABA alterations in the anterior 
cingulate and occipital cortex were quantified. In accordance with our results, 
they observed a GABA associated significant mean drop of 15.1% during pain 
stimulation (we observed a drop of 10.88%). They argued that the observed 
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drops could reflect a down-regulation of inhibitory neurotransmission associated 
with neuro-regulatory processes. Opposed to Cleve et al. and to the study 
presented here, Kupers et al. (2009) compared neurochemical alterations in the 
pregenual anterior cingulate cortex associated with tonic heat stimulation and 
found increases in GABA concentration. A reason for this discrepancy could be 
rooted in the different regions examined as well as the variety of MRS-sequences 
applied. Likely most important are differences in the type of pain stimulus and 
application site used: As we and Cleve et al. (2015) applied a repetitive short 
phasic stimulus, Kupers et al. utilized tonic heat lasting throughout the whole 
MRS measurement. It is highly probable that different neurochemical pain 
processing dynamics are engaged in the measured regions, especially considering 
the functional diversity of brainstem compared to insular/cingulate/frontal 
areas. 
Despite robust evidence provided for GABA involvement in neurophysiologic and 
pathologic pain processing (derived from animal and human studies), the 
question still remains about which underlying neuronal processes may have 
given rise to the observed reduction in GABA in our study. First of all, the GABA-
signal obtained by means of 1H-MRS reflects all GABA in a defined voxel. 
Therefore, it is not possible to directly ascribe our observed concentration 
changes to specific GABA pools such as metabolic, vesicular and extrasynaptic 
compartments (GABA distributed in the extracellular fluid) (Stagg et al., 2011a). 
Also considerable is the fact that some of the pools are more tightly bound to 
macromolecules, thus reducing their contribution to the acquired GABA-signal 
(Stagg et al., 2011a). Animal 1H-MRS studies further suggest that the GABA-signal 
predominately reflects extrasynaptic GABA (which binds to extrasynaptic GABAA 
receptors) and therefore determines a general non-synaptic GABAergic tone 
(Stagg et al., 2011b). It is also important to mention that levels of measured 
GABA are not simplistically linked to excitatory activity and that an increase in 
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GABA concentration does not necessarily correspond to increased neuronal 
inhibition (Rae, 2014). It has generally been proposed that overall GABA levels 
rather reflect a gross GABAergic tone instead of specific inhibitory activity per se. 
In that vein, the GABA reduction observed in our study does not need to directly 
mirror increases in excitatory neurotransmission within the TBSNC due to 
nociceptive processing (coupled with glutamatergic excitatory 
neurotransmission). The applied dental stimuli were of 1 ms duration giving rise 
to associated short dental pain perceptions. In case of induced GABAergic 
neurotransmission, potentially released GABA into the synaptic cleft would 
probably be quickly taken up by astrocytes and neurons due to the short 
stimulation applied. Considering the timespan between excitation of the MRS 
volume until the end of the signal readout of approx. 572 ms, it is rather unlikely 
that such short neurotransmittory processes are measurable with the applied 1H-
MRS sequence. In this view, the presented results correspond to the view that 
the observed decrease in GABA levels may reflect changes in a general 
GABAergic tone rather than specific and direct GABAergic neurotransmission.  
 
Limitations:  
Several limitations need to be considered. Starting with the voxel placement, 
measuring the TBSNC with ideal anatomical and functional specificity proved to 
be highly demanding. This circumstance is attributable to the shape of the TBSNC 
and brainstem in general impeding measurability accuracy using the available 
cuboid voxel shape. Higher anatomical specificity might be attainable by applying 
other specificity enhancement strategies currently under development and 
partly applicable, like the use of arbitrary voxel shapes. This technique enables 
an exact drawing of the region of interest according to its structural contours 
thus theoretically achieving higher levels of spatial selectivity (Weber-Fahr et al., 
2009; Snyder et al., 2012). However, the lack of contrast of structural MRI in the 
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brainstem hampers the visual identification of TBSNC structures. This 
circumstance further aggravates the achievement of optimal specificity and 
resulting increase of sensitivity to neurochemical processes in the TBSNC.  
The exclusive assessment of the neurochemical milieu of the TBSNC ipsilateral to 
the stimulated tooth could represent a further limitation. An additional 
measurement of the contralateral TBSNC in rest and during dental stimulation 
could provide valuable insights regarding the lateralization specificity of the 
observed neurochemical alterations. In the same vein, an additional recovery 
phase after the pain condition could provide further information on the 
dynamics of the recorded neurochemical effects. Such examinations are planned. 
A possible limitation could be rooted in the exclusive participation of healthy 
male volunteers. The testing of a female population may demand an adaptation 
of voxel dimensions due to different brain sizes thus impeding a generalization of 
our results to the female population and further studies might be necessary.  
Further on, we would like to comprehensively address possible limitations 
regarding the observed changes in GABA.  
At 3 Tesla, detection and quantification of GABA is challenging as the signal 
significantly overlaps with resonances from other neurochemicals. Several 
approaches have been developed to improve the quantification of GABA at this 
field strength (Mescher et al., 1998; Schulte and Boesiger, 2006; Stagg, 2013). 
The most commonly and widely accepted gold-standard of GABA quantification 
at 3 Tesla is a spectral editing technique named MEGA-PRESS. This method 
allows the separation of the 4CH2-GABA multiplet from the overlapping 
resonances (Mescher et al., 1998). MEGA-PRESS is a two-step approach which 
requires the acquisition of “on and off” spectra to calculate the edited spectrum. 
To date, with respect to our paradigm and the neurochemical quantification 
within the TBSNC, this method is not applicable due to required voxels sizes and 
measurement time (high volunteer stress).  
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Another technique able to improve GABA quantification is 2D J-resolved MRS in 
combination with two-dimensional fitting procedures (Schulte and Boesiger, 
2006; Stagg, 2013). However, this approach is also limited within the frame of 
the present study as significantly larger voxel sizes and longer scan times are 
required to achieve sufficient SNR.   
In this report, MRS sequences and post-processing techniques are based on 
spinal cord MRS Hock et al., 2013; Hock et al., 2013a; Hock et al., 2016) and are 
optimized for quantification of neurochemical profiles in the TBSNC. Although 
methodological work suggests that unedited short-TE MRS measurements at 3 
Tesla can yield relatively reliable GABA quantification, distinct caution must be 
applied regarding the spectral quality between conditions, as differences in 
linewidth and SNR systematically bias GABA quantification and fitting error 
estimates (Near et al., 2013). In that sense, special care was applied to ensure 
comparable spectral quality estimates (linewidth and SNR) between the baseline 
and pain condition, hence minimizing systematic quantification biases between 
both conditions (reported in table 1). Another consequence of the resonance 
overlaps from GABA and other neurochemicals are increased GABA fitting errors. 
As rule of thumb, neurochemicals determined with CRLB < 20-30% are not 
considered unreliable, but should be interpreted with caution (De Graaf, 2007). 
Although mean CRLB for GABA in both conditions meet this criterion, it is 
important to emphasize that CRLB only reflect lower bounds and therefore may 
underestimate the actual magnitude of fitting errors. To overcome mentioned 
limitations we are working on the adaptation of the metabolic cycling technique 
for the use at 7 Tesla. Additionally, we are working on optimized coil designs to 
maximize SNR as successfully shown for the spinal cord (Hock et al., 2016). 
 
 
 
 112 
Conclusion 
Conceptualized as a feasibility study, this 1H-MRS investigation provides first 
evidence of neurochemical alterations in the human TBSNC during experimental 
orofacial pain. Yet, the findings need to be cautiously interpreted, replication as 
well as expanding the research focus is indispensable.  
We would like to note that the application of 1H-MRS at the level of the TBSNC is 
possible, allowing the study of neurochemical compositions also in other 
brainstem subareas. Important in this regard is the measurement quality of 
tNAA, GABA and the six other quantified neurochemicals (table 1 and 2). 
Important, since we think that orofacial pain is mediated not only by tNAA and 
GABA. We rather hypothesize that the general neurochemical composition is 
somehow involved to code all complex intertwined facets of the human neural 
pain circuits. This has to be explored in following studies.  
This study provides first indications of human brainstem neurochemical 
nociceptive mechanisms. Hence, it complements identified neurochemical 
aberrations in animal models of acute/chronic orofacial pain. Thus, bridging both 
research fields might be in reach and offers hope for successful new treatment 
opportunities.  
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5.2.6 Supplementary Material 
 
Figure 1: Graphical illustration of movement estimates of all volunteers from 
navigator 1 (Nav I; anterior-posterior, AP) recorded during baseline and pain 
conditions. The gating window of ± 1mm is represented by the red lines.  
 
  
-8
-6
-4
-2
0
2
0 5 10 15 20 25
D
is
p
la
ce
m
e
n
t 
[m
m
] 
Time [minutes] 
Nav I - Baseline Condition 
-8
-6
-4
-2
0
2
0 5 10 15 20 25
D
is
p
la
ce
m
e
n
t 
[m
m
] 
Time [minutes] 
Nav I - Pain condition 
 114 
 
 
Figure 2: Graphical illustration of movement estimates of all volunteers from 
navigator 2 (Nav II; left-right, LR) recorded during the baseline and pain 
condition. The gating window of ± 1mm is represented by the red lines. The 
movement time-series of two participants (blue and green) showed excessive 
noise levels, thus were excluded from the movement group analysis.  
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Figure 3: Depiction of movement estimates from Nav II (LR) recorded during the 
baseline and pain condition. The gating window of ± 1mm is represented by the 
red lines. This is the same illustration as shown in figure 2 without the two noisy 
movement profiles. 
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Figure 4: Exemplary, the movement profiles from one excluded participant. The 
gating window of ± 1mm is represented by the red lines. The exclusion decision 
was based on the prominent AP drift during the pain-condition (Nav I in panel 2), 
shifting over 73% of the navigator echoes outside the gating window (Respective 
information provided in table 3 of the main manuscript).  
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5.3.1 Abstract 
Converging lines of evidence indicate that the pain experience emerges from 
distributed cortical nodes that share nociceptive information. While the theory 
of a single pain center is still not falsifiable by current neuroimaging technology, 
the validation of distinct brain mechanisms for acute pain and its relief is ongoing 
and strongly dependent on the employed experimental design. In the current 
study including a total of 28 subjects, a recently presented, innovative 
experimental approach was adopted that is able to clearly differentiate painful 
from non-pain perceptions without changing stimulus strength and while 
recording brain activity using functional magnetic resonance imaging (fMRI). 
Namely, we applied a repetitive and purely nociceptive stimulus to the tooth 
pulp with subsequent suppression of the nociceptive barrage via a regional nerve 
block. The study aims were 1) to replicate previous findings of acute pain 
demonstrating a fundamental role of the operculo-insular region and 2) to 
explore its functional connectivity during pain and subsequent relief. The brain 
activity reduction in the posterior insula (pINS) due to pain extinction was 
confirmed. In addition, the posterior S2 region (OP1) showed a similar activity 
pattern, thus confirming the relevance of the operculo-insular cortex in acute 
pain processing. Furthermore, the functional connectivity analysis yielded an 
enhanced positive coupling of the pINS with the cerebellar culmen during pain 
relief, whereas the OP1 demonstrated a positive coupling with the posterior 
midcingulate cortex during pain. The current results support the conceptual 
synthesis of localized specialization of pain processing with interactions across 
distributed neural targets. 
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5.3.2 Introduction 
Ronald Melzack proposed that each bodily sensation is reflected in the human 
brain as a result of characteristic neural impulse patterns, and accordingly, he 
coined the term “neurosignature pattern for pain” (Melzack 1990). The brain 
regions concomitantly activated by noxious stimuli collectively have been named 
the “pain matrix” or “pain signature”. These include the thalamus, primary and 
secondary somatosensory cortices (S1 and S2), insular cortices, the anterior 
cingulate cortex (ACC), frontal cortices and the cerebellum (Peyron et al. 2000; 
Apkarian 2013; Moulton et al. 2010; Duerden and Albanese 2013). Increased 
activity in these areas does not necessarily imply pain selectivity but likely 
reflects additional unrelated processes. Regardless of whether it is nociceptive in 
nature, the pain matrix activity can be evoked by any salient or behaviorally 
relevant stimulus and might not reflect the qualitative change from non-painful 
to painful perception (Mouraux et al. 2011). Furthermore, accumulating 
evidence indicates that the pain experience is not dedicated to a specific “pain 
center” but rather is constructed from distributed nodes that share 
(anti)nociceptive information (Mano and Seymour 2015; Davis et al. 2015; Kucyi 
and Davis 2015). Recent advances led to a synthesis of perspectives that 
reconciles the localized specialization of pain processing with an appreciation for 
properties that emerge from interactions across distributed brain sources 
(Matthews and Hampshire 2016; Davis et al. 2015). Wager and colleagues 
convincingly demonstrated the existence of a “neural pain signature (NPS)” that 
discriminates between painful and non-painful brain states across many task 
conditions and subjects (Wager et al. 2013). However, because the NPS 
incorporates brain regions that are likely unrelated to nociception proper, e.g., 
the primary visual cortex, it raised questions about nociceptive specificity owing 
to a lack of evidence for nociceptive input to those brain areas (Apkarian 2013). 
Converging evidence from animal and human studies using central (intracortical) 
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and peripheral stimulation suggests the existence of nociceptive afferents 
passing the thalamus, the cerebellum, the S1 and S2, the midcingulate cortex and 
the posterior insula (pINS) (Kenshalo et al. 2000; Moulton et al. 2010; Shyu et al. 
2010; Garcia-Larrea 2012b; Mazzola et al. 2012a; Vierck et al. 2013; Craig 2014). 
In humans, the pINS and the adjacent parietal operculum (S2 region) show the 
uppermost preference for nociceptive signal processing, constituting a promising 
“core nociceptive node” (Eickhoff et al. 2006a; Garcia-Larrea 2012a; Mazzola et 
al. 2012b; Mazzola et al. 2012a; Segerdahl et al. 2015; Cowan 1977; Mano and 
Seymour 2015; Meier et al. 2015; Davis et al. 2015). Yet, while the theory of a 
single pain center is still not falsifiable by current neuroimaging technology, the 
validation of distinct brain mechanisms for acute pain and its relief is ongoing 
and highly dependent on the employed experimental design. Various 
confounding and pain-unrelated effects, such as the magnitude estimation 
associated with the cognitive and/or motor aspects of pain intensity rating, 
might blur the pain-associated neural effects (Baliki et al. 2009). Additionally, 
most pain studies performed categorical comparisons among different stimulus 
strengths, covering noxious and non-noxious stimulus ranges (Coghill et al. 1999; 
Brugger et al. 2012; Meier et al. 2012; Wager et al. 2013). Therefore, the neural 
substrate of such comparisons might be influenced by the diversity of stimulus 
strengths. Although efforts have been made to control for such effects by means 
of advanced statistical modeling (Oertel et al. 2012), it is challenging to design a 
proper experimental paradigm with the aim of enhancing the pain-related 
attribution of neuroimaging findings. Recently, we opted for an alternative 
approach to clearly differentiate painful from non-pain perceptions without 
changing stimulus strength (Meier et al. 2015). In this approach, the noxious 
stimulus intensity applied to a tooth was kept constant whereas the nociceptive 
signaling was interrupted by a local analgesic during functional magnetic 
resonance imaging (fMRI). In support of the current pain neuroimaging 
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literature, a significant and exclusive reduction in brain activity in the pINS, after 
blocking the nociceptive barrage, was observed. The current report is based on 
an identical approach, but it additionally includes a placebo condition to 
replicate or dismiss the presumed pain processing preference of the operculo-
insular cortex. Furthermore, its potential neural interactions with other brain 
regions were assessed during pain and its relief using generalized psychophysical 
interactions (gPPI). Herein, we expected to find novel and distinct functional 
connectivity measures that are strongly related to pain and its relief. 
 
5.3.3 Methods 
Subjects 
In addition to the 14 subjects described in our previous report (Meier et al. 
2015), the current report involves data from a total of 28 subjects (mean age = 
27.32, SD = 7.43). The right-handed male subjects were recruited by an 
advertisement published on an online marketplace (www.marktplatz.uzh.ch) and 
were enrolled after having given informed written consent. The subjects were 
randomly assigned (using the random function implemented in Microsoft Excel) 
to two groups: one group (Group A) received a dental anesthetic (see 2.2.3), 
whereas the other group (Group P) served as a control by receiving a placebo 
(NaCl). The groups were age-matched (independent two-Sample t-test, t = 1.36, 
p = 0.18). The subjects received 50 Swiss francs per hour. The study was 
conducted according to the Declaration of Helsinki and was approved by the 
Ethics Committee Zurich, Switzerland. 
The exclusion criteria were systemic disease, a history of allergy to the 
components of the local anesthetic solutions, local anesthesia at least 2 weeks 
before the experiment, caries, large restorations, periodontal disease, dental 
anxiety or a history of trauma or sensitivity of the mandibular canines. Dental 
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anxiety was assessed by the Dental Anxiety Scale (DAS) questionnaire (Corah 
1969). The mean DAS score was 6.57 (score range [4-11], SD = 1.95), indicating 
no dental anxiety in any subject, and did not differ between the groups 
(independent two-sample t-test, t = 0.08, p = 0.93). Alcohol was prohibited for 12 
h before the experiment. The fMRI measurements were performed between 1 
p.m. and 9 p.m. 
 
Materials 
Dental Splint 
The mandibular splints were constructed from impressions made of Blu-Mousse 
(Blu-Mousse is a fast- setting vinyl polysiloxane material produced by Parkell, 
Inc., 300 Executive Drive, Edgewood, NY 11717, USA). Stainless steel electrodes 
were embedded in each splint at the labial and palatal centers (they served as 
anode and cathode) of the left and right mandibular canine. A small portion of a 
specifically prepared contact hydrogel was placed on the anode and cathode to 
minimize electrical resistance during stimulation. Furthermore, particular care 
was taken that the splints did not evoke pain or discomfort (Meier et al. 2015). 
 
Electrical Stimulation 
The “Compex Motion” system has been proven to evoke reliable sharp and 
pricking pain sensations and is described in details elsewhere (Keller et al. 2002; 
Brugger et al. 2012; Brugger et al. 2011; Meier et al. 2014; Meier et al. 2015). The 
Presentation® software (http://www.neurobs.com/presentation) was used to 
control the experimental protocol. Shielded wires were used to avoid the 
radiofrequency contamination by the stimulation current. 
 
Dental Anesthetic and Placbo 
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For the anesthetic mental nerve block, articaine was used, which is currently the 
most common local dental anesthetic in Europe and has a long history of success 
(Cowan 1977). Articaine (4-methyl-3-[2- (propylamino)-propionamido]-2-
thiophene-carboxylic acid, methyl ester hydrochloride) blocks nociceptive input 
by binding reversibly to sodium channels and subsequently reducing sodium 
influx (Becker and Reed 2012). The pulp analgesia lasts for one to two hours. 
Since small trigeminal fibers are generally more susceptible to local anesthetic 
solutions than thickly myelinated fibers, differential sensitivities are commonly 
observed in clinical dentistry as patients may remain disturbed by a sense of 
pressure despite complete analgesia (Becker and Reed, 2012). The pain offset 
times reported in the current study are in line with other studies reporting pulpal 
anesthesia onsets and the related inter-subject variability (Chumbley and Friston 
2009; Kambalimath et al. 2013). In the current study, 0.6 ml of 4% solution 
containing 1:100,000 epinephrine was injected at the left mental foramen by a 
single trained and blinded dentist (JA) according to the technique described by 
Schwenzer and Ehrenfeld (Schwenzer and Ehrenfeld 2009). For the placebo, an 
equal amount of 0.9% saline solution (NaCl) was used. 
 
Psychophysical Assessment 
Outside MR Scanner 
Within 3-6 weeks prior to the fMRI experiment, the noxious intensity (NI) was 
determined and the dental anesthetic was injected. Subsequent stimulations 
were performed in separate sessions where subject reports regarding stimulus 
perception were recorded. Accompanied by detailed instructions, this procedure 
allowed for familiarizing the subjects with the anesthetic injection to minimize 
any arousal/anxiety effects and to guarantee a timely synchronized procedure 
across all subjects during the fMRI measurements. 
 
 133 
Inside MR Scanner 
While the subjects were positioned in the MR scanner, the sensory detection 
threshold (SDT), pain detection threshold (PDT) and NI were individually 
determined by applying an ascending method of limits. The left lower canine was 
stimulated with increasing intensity (1-mA steps) at randomized intervals 
between 8 and 12 s with a duration of 1 ms. The subjects were asked to indicate 
the SDT and PDT by pressing the alarm bell of the MR system. The NI was 
determined by further increasing the stimulus strength until the subject rated a 
“5” (corresponding to a painful, but tolerable perception) on a verbally 
instructed 11-point numeric rating scale (NRS) by pressing the alarm bell. The 
instructed NRS endpoints were “no pain” and “worst pain imaginable." All 
threshold determinations (SDT, PDT and NI) were repeated three times, and the 
mean NI was applied in the subsequent stimulation paradigm. Furthermore, the 
pain quality was assessed by the verbal descriptors of “pricking,” “dull” and 
“pressing.” These three descriptors have demonstrated discriminative properties 
to distinguish between A-delta- and C-fiber-mediated pain (Beissner et al. 2010). 
In a first phase (phase 1), the lower left canine was stimulated 30 times with the 
predefined NI at randomized intervals of 8 to 12 s. Afterwards, the subjects were 
instructed that they would receive either a dental anesthetic or a saline solution 
with no anesthetic effects (placebo). For the purpose of the injection, the original 
MR scanner bed position was memorized by the MR system and subsequently 
modified for an optimal local anesthesia setting followed by a submucosal 
injection (Figure 1) of either 4% articaine (Group A) or 0.9% NaCl (Group P). At 
the same time, the duration of the injection, including the exact re-positioning of 
the scanner bed, was maintained below one minute. 
Immediately following the injection of articaine or placebo, the subjects 
continued to receive repetitive electrical stimuli with equal strength as in phase 
1. In the course of this second stimulation phase (phase 2), the subjects were  
 134 
asked to report the possible pain offset (analgesia) by pressing the MR alarm bell 
once. In case of reporting pain offset, subjects subsequently received 30 stimuli 
with predefined NI. In the case of no further perception (complete anesthesia), 
the subjects were asked to press the alarm bell twice. 
 
Image Acquisition 
Functional and anatomical scans were obtained using a 3-T Phillips Ingenia 
scanner with a 15-channel receive-only head coil. The functional blood 
oxygenation level-dependent (BOLD) time series were recorded with a single-
shot echo-planar imaging sequence (SENSE-sshEPI) to acquire 33 axial whole 
brain slices. The following acquisition parameters were used: echo time (TE) = 30 
ms, repetition time (TR) = 2524 ms, FOV = 22 cm, acquisition matrix = 128 x 128, 
voxel size: 2.75 x 2.75 x 4.00 mm3, flip angle = 78° and SENSE acceleration factor 
R = 2.0. Using a mid-sagittal scout image, we placed 33 contiguous axial slices at 
20-degree angles to the anterior-posterior commissure (AC-PC) plane, covering 
the whole brain. The first stimulation phase consisted of 120 functional volumes. 
After injection, the second stimulation phase consisted of 400 volumes in Group 
A and 120 volumes in Group P. A high-resolution T1-weighted anatomical image 
(field of view [FOV] = 22 cm, voxel size = 2.00 x 2.00 x 2.00 mm3, 170 slices) was 
recorded for each subject. 
 
Preprocessing 
Preprocessing of the functional brain images was conducted with the statistical 
parametric mapping software program SPM12 (release 6685, Wellcome 
Department of Imaging Neuroscience, London, UK; http://www.fil.ion.ucl. 
ac.uk/spm/). All volumes of the EPI sequence were corrected for slice timing, 
and, subsequently, a spatial realignment to the first image in the series as a 
reference was performed. Slices with a detected movement that exceeded 2 mm 
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(translational) or 1° (rotational) in relation to the reference were removed. For 
studying the group effects, the data were normalized to the ICBM space 
template – European brains using seven-degree B-spline interpolation followed 
by smoothing with a Gaussian kernel of 8 mm full-width-at-half-maximum 
(FWHM) (Evans et al. 1992). While smoothing is necessary to produce reliable 
estimates of statistical significance using the theory of Gaussian random fields, it 
should be noted that the size of the smoothing kernel can influence the 
estimation of the true spatial extent of brain activity (Stelzer et al. 2014). 
 
Statistical Modelling and Analysis 
Brain Activity Analysis 
Single subject and group analyses were performed with SPM12 (release 6685). A 
general linear model (GLM) was applied to partition the observed neural 
responses into components of interest, confounders and errors (Friston 1995). 
An event-related analysis estimated the BOLD responses evoked by the 
potentially noxious stimuli by modeling them as a delta function convolved with 
the canonical hemodynamic function as implemented in SPM12. The stimulus 
duration was 1 ms with a randomized interstimulus interval between 8 and 12 s. 
In the 1st level (single subject) analysis, all 30 noxious stimuli of phase 1 were 
modeled as a single regressor (“pain phase 1 regressor”) in both groups. In phase 
2, all 30 noxious stimuli of Group P were identically modeled (“pain phase 2 
regressor”). In Group A, the first painful stimuli and the pressing of the alarm bell 
were individually implemented as regressors of no interest, whereas the 
following 30 non-painful stimuli (“non-painful phase 2 regressor”) were modeled 
as regressors of interest. Additional confounders were incorporated in each 
analysis within the design matrix, including the six rotational and translational 
parameters from the rigid body transformation, obtained during the functional 
image realignment. Low-frequency fluctuations were removed with a high-pass 
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filter (128 s). The serial autocorrelation of the BOLD time series was modeled 
using a first-order autoregressive model (AR[1]). The computed contrast maps 
derived from each subject were then entered into a random effects (RFX) 
analysis. 
To properly limit the amount of false positives, whole-brain topological inference 
using a cluster-based false discovery rate method (FDR) based on Gaussian 
Random Field Theory was applied (Chumbley and Friston 2009). The cluster 
defining threshold was set to p < 0.001. An initial threshold of p < 0.001 is 
recommended to avoid the pitfalls associated with cluster-based thresholding 
(Woo et al. 2014; Eklund et al. 2016). Only clusters that survived the FDR 
correction were used for the interpretation of the results. For within-group 
analyses, one-sample t-tests were performed, whereas for between-group 
analyses, independent two-sample t-tests were used as implemented in SPM12. 
The variance between groups was assumed to be unequal. The error covariance 
components were estimated using restricted maximum likelihood (REML). The 
activations and deactivations associated with each regressor were tested by 
means of simple positive and negative t-contrasts. To uncover any possible pre-
injection differences in brain activity, phase 1 was compared between groups. 
Furthermore, the post-injection brain activity between groups was investigated 
by comparing phase 2. The potential effects of post- injection temporal 
discrepancies due to the additional painful stimuli in Group A can be neglected 
because adaptive changes in the sensory experience of the electrical stimulus 
within the experimental time window are not present (Brugger et al. 2012; Meier 
et al. 2014; Meier et al. 2015). Finally, the thresholded voxel SPM t-maps were 
color-coded and superimposed onto the avg152T1-MNI brain using xjview 
(http://www.alivelearn.net/xjview8/). To determine the exact OP area of the S2 
region, the SPM anatomy toolbox (version 2.2c) was used (Eickhoff et al. 2005; 
Eickhoff et al. 2006b). 
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Functional Connectivity Analysis 
The main advantage of the PPI analysis is that it assesses the co-variance 
between regions across time during a certain task, and therefore provides a test 
of task effects on connectivity. The generalized form of the context-dependent 
PPI approach (gPPI) increases the flexibility of the statistical modeling and 
improves single-subject model-fit, thereby increasing the sensitivity to true 
positive findings and a reduction in false positives (McLaren et al. 2012). 
Importantly, the co-variance is assessed on the neural level, which results in a 
change in the BOLD signal, rather than at the level of the BOLD signal, which is an 
indirect measure of neural activity (McLaren et al. 2012; Kim and Horwitz 2008). 
Therefore, a deconvolution step is mandatory to capture the neural signal on 
which the interaction analyses are performed. As such, the gPPI model might 
better capture the BOLD response and the associated underlying neural activity 
than a conventional task regressor. However, these analyses are not able to 
reveal directed links between regions (i.e., activity in region A causes activity in 
region B). Instead, these analyses allow inferences about the co-activation of 
regions across subjects and time, whereas the strength of co-activation is 
modulated by the task state (pain/analgesia). 
For each subject, we extracted the deconvolved time course of 6 mm-spheres 
with peak coordinates of pain-related activity in the pINS and OP1 areas 
identified in the between-group brain activity analysis of phase 2 (see 3.3.2, MNI 
coordinates OP1: 54 -20 16, pINS: -42 -8 -4). Subsequently, separate 
psychological (pain/relief) and physiological regressors (time course of seed 
regions) and their PPI interaction, as well as the movement parameters, were 
included in the gPPI model. Furthermore, to avoid circularity, the main effect of 
the task was also modeled to detect functional connectivity effects over and 
above (orthogonal to) the main effect of the task (O'Reilly et al. 2012). The 
resulting whole-brain gPPI connectivity estimates were then evaluated using a 
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two sample t-test implemented in SPM12. The identified clusters were 
considered to be significant when falling below a cluster-corrected q (FDR) < 
0.05. 
 
5.3.4 Results 
Stimulus Perception and Pain Relief 
The electrical stimulus strength of the NI in phase 1 (5/11 NRS) did not differ 
between groups (Mann- Whitney U-test, p = 0.7). None of the subjects indicated 
any sensitization/habituation effects of the repetitive pain stimulus. 
Furthermore, all subjects reported a pricking pain perception, indicating 
predominantly A-delta fiber-mediated pain. Following the injection, the pain 
stopped at 2.8 min (SD = 3.73 min) in Group A. Although no longer painful, the 
stimulus was always perceived by the subjects, indicating incomplete anesthesia. 
In Group P, no subjects reported pain relief. 
 
Brain Activity Results 
Overall Brain Activity Phase 1 (Pain Phase) 
The pooled group analysis of brain activation induced by the noxious stimulation 
yielded activity in several brain regions commonly reported in pain studies: 
insular, cingulate and somatosensory cortices, cerebellum, thalamus and frontal 
brain regions (q(FDR) < 0.05, Figure 1a, Table 1a). 
For the brain activity results of phase 2 within each group (Figures 1b and 1c) 
please see Tables 1b and 1c. 
 
Group Differences 
Importantly, the between-group analysis of phase 1 revealed no significant 
activation differences (Table 1d). In contrast, the between-group comparison of  
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Table 1. Brain activity results of Phase 1 and Phase 
2       
                
  Phase 1 > baseline, pooled groups (one-sample t-test, N = 28)   
a. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  971 <0.001 6.7 -2 -24 34 PCC 
  1543 <0.001 6.64 -38 9 -10 Left insula 
  2103 <0.001 6.58 50 44 10 Right DLPFC 
  487 <0.001 6.32 40 -2 -4 Right Insula 
  2951 <0.001 6.17 -2 -82 -16 Left cerebellum 
  721 <0.001 5.94 -54 -46 32 Left IPC 
  1176 <0.001 5.88 62 -40 38 Right IPC 
  224 <0.002 5.64 -42 50 12 Left DLPFC 
  259 <0.001 5.38 38 18 44 Right MFC 
  385 <0.001 4.88 0 28 32 aMCC 
  453 <0.001 4.51 18 -6 8 Right Thalamus 
  141 <0.014 4.45 32 -82 -28 Right cerebellum (declive) 
                
  Phase 2 > baseline, Group A (one-sample t-test, N = 14)     
b. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  1242 <0.001 6.68 48 34 18 Right DLPFC 
  680 <0.001 5.53 48 -44 48 Right SPC 
  369 <0.001 5.2 -34 26 30 Left DLPFC 
  301 <0.001 5.14 4 36 34 aMCC 
  266 <0.001 5.12 -10 -16 16 Left Thalamus 
  197 <0.004 4.98 24 54 -12 Right VLPFC 
  131 <0.02 4.77 -10 -86 -30 Left Cerebellum (declive) 
  169 <0.009 4.69 -28 -74 -28 Left Cerebellum (declive) 
  137 <0.02 4.55 36 -60 -28 Right Cerebellum (declive) 
  135 <0.02 4.29 14 -20 16 Right Thalamus 
  113 <0.04 4.25 8 -76 40 Right IPC 
                
  Phase 2 > baseline, Group P (one-sample t-test, N = 14)     
c. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  13987 <0.001 8.24 34 38 26 Right DLPFC 
  9887 <0.001 8.23 10 24 42 Right aMCC 
  6189 <0.001 7.64 -44 -6 -4 Right insula 
  473 <0.001 6.06 12 -12 8 Right Thalamus 
  601 <0.001 5.94 6 -18 32 Right PCC 
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  120 <0.001 5.57 -38 -24 16 Left insula 
  207 <0.002 5.35 -56 -64 6 Left IPC 
  401 <0.001 5.23 -12 -8 12 Left Thalamus 
  567 <0.001 5.17 0 -82 6 OC 
  106 <0.05 5.01 -14 14 62 Left SMA 
  202 <0.04 4.79 -6 -66 -32 Left Cerebellum (pyramis) 
                
  Group differences, Phase 1 (two-sample t-test, N = 28)     
  Group A > Group P, Group P > Group A       
d. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  No significant clusters           
                
  Group differences, Phase 2 (two-sample t-test, N = 28)     
  Group A > Group P           
e. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  98 <0.05 5.54 -42 -8 -4 Left insula 
  
61 <0.05 4.69 54 
-
20 
16 Right S2 (OP1) 
                
  MNI = Montreal Neurological Institute, FDR = False discovery rate, PCC = posterior cingulate 
cortex, aMCC = anterior midcingulate cortex, DLPFC = dorsolateral prefrontal cortex, VLPFC = 
ventrolateral prefrontal cortex, IPC = inferior parietal cortex, SPC = superior parietal cortex, MFC = 
middle frontal gyrus, S2 = secondary somatosensory cortex, OC = occipital cortex 
  
  
  
 
phase 2 revealed a distinct activation difference, reflected by persistent 
activation clusters in the ipsilateral pINS (q(FDR) < 0.05, peak MNI coordinate: -
42 -8 -4, Figure 2a, Table 1e) and the contralateral S2 region, extending into the 
inferior parietal lobule (q(FDR) < 0.05, peak MNI 54 -20 16, Figure 2b, Table 1e) in 
Group P. Feeding the SPM anatomy toolbox with the peak coordinate [54 -20 16] 
yielded a probability of 56% (range 42-67%) for belonging to area OP1 and a 12% 
(range 9-13%) probability for OP4. 
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Functional Connectivity Results 
Overall Functional Connectivity Phase 1 
Using the pINS as a seed (Figure 3c), the pooled group analysis yielded an 
enhanced positive functional connectivity during noxious stimulation to the 
ipsilateral insula, bilateral ventrolateral prefrontal cortex (VLPFC), S1 and S2, 
superior parietal cortex (SPC) and inferior frontal gyrus (IFG) (q(FDR) < 0.05, 
Table 2a). 
In contrast, the OP1 region (Figure 3a) revealed a positive functional coupling to 
the bilateral S2, right supplementary motor area (SMA), bilateral inferior parietal 
cortex (IPC), bilateral thalamus, left posterior midcingulate cortex (pMCC), 
caudate, cerebellum, and right occipital cortex (OC) (q(FDR) < 0.05, Table 3a). 
For the functional connectivity results of phase 2 within each group please see 
Tables 2b, 2c (for pINS) and 3b, 3c (for OP1). 
 
Group Differences 
Using the pINS as a seed, phase 1 revealed no significant group differences (Table 
2d). The between- group analysis of phase 2 demonstrated a positive functional 
coupling of the pINS exclusively to the culmen of the left cerebellum during pain 
relief (q(FDR) < 0.001, Figure 3d, Table 2e). The reverse contrast, Group P (phase 
2) > Group A (phase 2), revealed no significant results. 
In contrast, the OP1 between-group analysis yielded a significant enhanced 
functional coupling to bilateral clusters of the pMCC region during noxious 
stimulation (q(FDR) < 0.03, Figure 3d, Table 3e). The reverse contrast, Group A 
(phase 2) > Group P (phase 2), revealed no significant results. 
5.3.5 Discussion 
Our study results contribute to the ongoing validation of distinct pain-related 
brain mechanisms (Mano and Seymour 2015; Kucyi and Davis 2015; Davis et al.  
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Table 2. Functional connectivity results of Phase 1 and Phase 2 with pINS seed region 
                
  Phase 1 > baseline, pooled groups (one-sample t-test, N = 28)   
a. cluster size q(FDR) t MNI Peak coordinates (mm) Brain Region 
  119 <0.005 7.28 -40 -6 -6 Left insula 
  142 <0.002 6.06 48 38 -6 Right VLPFC 
  243 <0.001 5.81 56 -30 32 Right S2 
  180 <0.001 5.64 -16 -62 48 Left SPC 
  428 <0.001 5.5 56 22 22 Right IFG 
  210 <0.001 5.5 -48 10 12 Left IFG 
  127 <0.004 5.23 -40 34 2 Left VLPFC 
  146 <0.002 5.15 40 -38 60 Right PCG 
                
  Phase 2 > baseline, Group A (one-sample t-test, N = 14)     
b. cluster size q(FDR) t MNI Peak coordinates (mm) Brain Region 
  584 <0.001 6.21 -14 -60 -26 Left Cerebellum 
  278 <0.001 6.2 -42 6 -10 Left insula 
  177 <0.004 5.86 -16 -30 -28 Pons 
  
87 <0.05 5.12 10 -64 -28 
Right Cerebellum 
(declive) 
  255 <0.001 5.04 40 12 -8 Right insula 
  173 <0.004 5.01 22 -62 -4 Right fusiform gyrus 
  114 <0.02 4.87 2 -8 8 Right Thalamus 
  
236 <0.001 4.74 34 -62 -22 
Right Cerebellum 
(declive) 
  110 <0.02 4.39 -6 22 30 aMCC 
                
  Phase 2 > baseline, Group P (one-sample t-test, N = 14)     
  cluster size q(FDR) t MNI Peak coordinates (mm) Brain Region 
c. No significant clusters           
                
                
  Group differences, Phase 1 (two-sample t-test, N = 28)     
  Group A > Group P, Group P > Group A       
d. cluster size q(FDR) t MNI Peak coordinates (mm) Brain Region 
  no significant clusters           
                
                
  Group differences, Phase 2 (two-sample t-test, N = 28)     
   Group A > Group P           
e. cluster size q(FDR) t MNI Peak coordinates (mm) Brain Region 
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  289 <0.001 5.49 -14 -54 -28 Left cerebellum (culmen) 
                
  Group P > Group A           
                
  No significant clusters           
                
MNI = Montreal Neurological Institute, FDR = False discovery rate, VLPFC = ventrolateral prefrontal 
cortex, SPC = superior parietal cortex, S2 = secondary somatosensory cortex, IFG = inferior frontal 
gyrus, PCG = postcentral gyrus 
 
2015; Garcia-Larrea 2012b). The main finding confirms the prominent role of the 
operculo-insular cortex as an important node in pain processing. Furthermore, 
we identified novel and distinct neural interactions between the pINS/pMCC and 
OP1/cerebellum, indicating two functionally separate mechanisms during pain 
perception and relief. 
 
Stimulus 
The idea behind selecting a tooth as a target site for a purely nociceptive 
stimulus is not new (Chatrian et al. 1975) and relies on the observation that 
repetitive electrical stimuli reliably evoke painful short and sharp sensations (A-
delta fiber-mediated pain) and no superimposed mechano- or thermosensations 
(Narhi et al. 1992; Brugger et al. 2011; Brugger et al. 2012; Meier et al. 2015; 
Meier et al. 2014). Nociceptive fibers are generally more susceptible to local 
analgesics than thickly myelinated fibers, as clinically demonstrated by a 
pressure sensation during dental extractions despite complete analgesia (Becker  
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Table 3. Functional connectivity results of Phase 1 and Phase 2 with OP1 seed region 
                
  Phase 1 > baseline, pooled groups (one-sample t-test, N = 28)   
a. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  3451 <0.001 7.88 -52 -26 16 Left S2 
  1085 <0.001 7.55 54 -20 16 Right S2 
  2666 <0.001 7.07 4 -4 60 Right SMA 
  610 <0.001 5.76 -18 -82 28 Left IPC 
  1638 <0.001 5.72 20 -82 -4 Right OC 
  496 <0.001 5.62 14 -82 20 Right IPC 
  553 <0.001 5.41 6 6 40 Left pMCC 
  309 <0.001 4.94 -46 -46 -28 Left cerebellum 
  97 <0.003 4.7 2 -14 16 Right Thalamus 
  182 <0.001 4.59 -2 10 6 Left caudate 
  86 <0.04 4.39 -18 -20 14 Left Thalamus 
                
  Phase 2 > baseline, Group A (one-sample t-test, N = 14)     
b. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  875 <0.001 7.31 8 10 36 aMCC 
  1611 <0.001 6.31 62 -20 14 Right S2 
  641 <0.001 5.76 -50 -24 10 Left S2 
  143 <0.004 5.72 20 -6 -24 Right Amygdala 
  114 <0.02 5.56 26 -14 0 Right putamen 
  168 <0.002 4.57 8 -60 -26 Right Cerebellum (fastigium) 
                
  Phase 2 > baseline, Group P (one-sample t-test, N = 14)     
  cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  5851 <0.001 8.81 -6 6 36 aMCC 
  169 <0.002 6.59 54 -22 12 Right S2 
  137 <0.004 6.49 -38 -2 44 Left MFG 
  105 <0.02 5.72 -18 -84 30 Left IPC 
  252 <0.001 5.38 -28 -38 62 Left PCG 
  247 <0.001 5.25 50 -24 32 Right PCG 
  157 <0.003 5.22 22 -78 30 Right IPC 
  Group differences, Phase 1 (two-sample t-test, N = 28)     
d. Group A > Group P           
  cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  No significant clusters           
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  Group P > Group A           
                
  No significant clusters           
                
  Group differences, Phase 2 (two-sample t-test, N = 28)     
  Group A > Group P           
e. cluster size q(FDR) t 
MNI Peak coordinates 
(mm) Brain Region 
  No significant clusters           
                
  Group P > Group A           
                
  149 <0.003 5.56 16 10 44 Right pMCC 
  71 <0.03 5.2 -12 4 36 Left pMCC 
  
MNI = Montreal Neurological Institute, FDR = False discovery rate, aMCC = anterior midcingulate 
cortex, pMCC = posterior midcingulate cortex, DLPFC = dorsolateral prefrontal cortex, IPC = inferior 
parietal cortex, S2 = secondary somatosensory cortex, SMA = supplementary motor area, OC = 
occipital cortex, MFG = middle frontal gyrus, PCG = postcentral gyrus 
  
and Reed 2012). Correspondingly, the subjects in our experiment reported that 
electrical stimuli evoked a distinct non-painful sensation at the target tooth after 
the onset of analgesia, which permitted a task-based activity and connectivity 
analysis. Furthermore, adaptive changes in the perception of the painful 
repetitive electrical stimulus (sensitization/habituation) within the time frame of 
the experiment were minimal as demonstrated in our previous experiments 
(Meier et al. 2015; Meier et al. 2014; Brugger et al. 2012). This allowed the 
exclusion of a continuous pain rating task that prevented the possible blurring 
effects associated with cognitive and/or motor aspects of pain intensity rating 
(Baliki et al. 2009; Oertel et al. 2012). 
 
Posterior Insula and Parietal Operculum 
The current results confirm accumulating evidence from human reports 
demonstrating that the operculo- insular region is the most consistently  
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activated area in acute pain (Garcia-Larrea 2012a; Oertel et al. 2012; Duerden  
and Albanese 2013; Favilla et al. 2014; Segerdahl et al. 2015). In support of this 
observation, the pINS and the medial parietal operculum are the only areas 
where electrical stimulation triggered somatic pain in pre-surgical patients 
(Mazzola et al. 2012b). Furthermore, electrophysiological recordings revealed 
that the earliest brain responses to noxious stimuli originate in the operculo- 
Figure 1: A. Overall brain activity results during the repetitive noxious stimulation in phase 1 (N = 
28, one sample t-test). B. Post-Injection (articaine, Group A, N = 14) brain activity during pain 
relief. C. Post-injection brain activity (NaCl, Group P, N = 14). All results are thresholded with 
q(FDR)<0.05, cluster-based corrected. 
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insular cortex (Garcia-Larrea et al. 2003). On the other hand, by using 
intracerebral recordings, it has been recently shown that the pINS also responds 
to stimuli unrelated to nociception, which confutes the widespread assumption 
that the pINS serves as a pain-specific center (Liberati et al. 2016). Nevertheless, 
one should be cautious to not overintepret these results as a specific 
involvement of the pINS in pain perception cannot be excluded. In particular, as 
the local field potentials used in that study reflect the firing of cell populations, 
pain-specific neurons in the pINS cannot be excluded and further research in this 
area is needed. Surprisingly, the current investigation revealed an ipsilateral (left-
sided) activation of the pINS. Yet, in contrast to the mainly contralateral 
spinothalamic input from spinal nerves, the trigeminal cortical representation is 
known to respond to ipsi- and bilateral receptive fields (Cusick et al. 1986; Lin et 
al. 1993; Jantsch et al. 2005). This is in keeping with observations from  
Figure 2: Between-group 
brain activity analyses (two 
sample t-test, N = 28). The 
contrast Group P (Phase 2) 
> Group A (Phase 2) 
showing brain activity 
strongly related to 
nociception revealed 
exclusive brain activity 
differences in the pINS (A) 
and S2 region (OP1). 
q(FDR)<0.05, cluster-based 
corrected. 
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Rasmussen and Penfield who elicited ipsi- and bilateral sensations from cortical 
stimulation of the face and oral cavity areas in awake humans (PENFIELD 1947; 
RASMUSSEN and PENFIELD 1947). Supporting this observation, a minority of 
mandibular branch proprioceptive afferents cross the midline, and thus ascend 
homolaterally to the thalamus (Chen et al. 1997), and the insular region is known 
to receive bilateral input from the trigeminus (Dong et al. 1989). Furthermore, 
our results are in agreement with an experimental tooth pain study which 
demonstrated bilateral S2 activation and a clear dominance of tooth over hand 
Figure 3: Whole-brain functional connectivity results using generalized psychophysical 
interactions (gPPI). The OP1 seed region (A) demonstrated an enhanced functional coupling to 
the aMCC during pain (B). The pINS seed region (C) showed an enhanced interaction with the 
cerebellar culmen during pain relief (D). q(FDR)<0.05, cluster-based corrected. 
 149 
representation in the ipsilateral insula, although the two different stimulation 
modalities might have contributed to this difference (tooth: electrical vs. hand: 
mechanical) (Jantsch et al. 2005). Nevertheless, as we only stimulated and 
anesthetized a single tooth, a final conclusion about lateralization effects cannot 
be drawn, which is an important study limitation. 
Furthermore, our results indicate a pain-related pINS activation that is located 
more anterior to the dorsal pINS activation reported in several pain studies 
(Henderson et al. 2011; Garcia-Larrea 2012a; Wager et al. 2013; Segerdahl et al. 
2015). However, electrical stimulations in pre-surgical patients elicited somatic 
pain not only in the dorsal pINS regions but also in the widely distributed 
anterior portions of the pINS (Mazzola et al. 2012a). Moreover, a somatotopic 
organization of pain within the insular cortex was suggested, with the face being 
represented anterior to the upper and lower limbs (Mazzola et al. 2009). In 
keeping with this observation, another study applying painful trigeminal CO2 
stimuli to the nasal mucosa revealed a pain-related activation in a more anterior 
region of the pINS that is comparable to the pINS activation of our study (Oertel 
et al. 2012). 
Regarding the human parietal operculum, it is classified into four distinct 
cytoarchitectonic areas (OP1-4) which can be interpreted as anatomical 
correlates of the functionally defined human S2 region (Eickhoff et al. 2006a; 
Eickhoff et al. 2006b). Our results indicate a contralateral (right-sided) neural 
response of the OP1 area. This is in line with a previous report that 
demonstrated a right-sided dominance of activation in the S2/subcentral area 
during bilateral painful electrical tooth stimulation (Brugger et al. 2011). A meta-
analysis indicated that painful stimuli are exclusively processed in the OP1 
region, whereas non-painful stimuli are represented in the OP 2-4 region 
(Eickhoff et al. 2006a). Further support for this observation comes from lesion 
studies (Greenspan et al. 1999; Greenspan and Winfield 1992). In contrast, 
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another investigation detected pain-related effects exclusively in the OP 4 
region, which raises doubts about a definitive answer regarding pain processing 
within the parietal operculum (Mazzola et al. 2012b). 
 
Cingulate Cortex 
Interestingly, the OP1 region demonstrated an enhanced functional coupling 
with the pMCC during noxious stimulation (Figure 3D). An anatomical 
classification of the cingulate cortex subregions has been proposed by Vogt and 
colleagues (Vogt et al. 2003; Vogt 2016). Of these, the MCC plays a key role in 
pain processing and is almost as consistently activated as the operculo-insular 
cortex (Vogt 2005; Frot et al. 2008). The observed neural interaction of the OP1 
region with the pMCC closely corresponds with a study using intracerebral 
recordings of laser-evoked potentials showing the simultaneous processing of 
nociceptive information in both brain regions (Frot et al. 2008). Although our 
results indicate a highly pain-related relationship between the OP1 and pMCC, 
no pain-only area has been identified in the cingulate cortex to date (Vogt 2016). 
Alternatively, a multidimensional view including behavioral goals such as 
avoiding noxious stimuli has been proposed (Vogt 2005). It is assumed that the 
pMCC is involved in the withdrawal reactions from the painful stimulus in 
maintaining connections to the motor cortex and SMA for the preparation of 
voluntary movements (Buchel et al. 2002; Niddam et al. 2005; Vogt 2016). 
Withdrawal from the pain stimulus has to be operational at very short latencies 
and is, therefore, not dependent on prior sequential processing through other 
cortical areas (Frot et al. 2008). 
 
Cerebellum 
Very few studies to date have attempted to unveil the cerebellum’s function in 
pain. A review by Moulton and colleagues summarizing animal and human 
 151 
reports indicated that the cerebellum receives primary nociceptive afferents and 
that the electrical and pharmacological stimulation of the cerebellum can 
modulate pain processing (Moulton et al. 2010). Further, cerebellar lesions can 
lead to altered pain perception (Ruscheweyh et al. 2014). Although cerebellar 
activity occurs consistently in the presence of acute pain (Apkarian et al. 2005; 
Peyron et al. 2000), little is known about the specific role of the cerebellum 
regarding pain perception. Recently, the posterior cerebellum has been shown to 
process the overlapping and multimodal inputs from motor control and pain 
(Coombes and Misra 2016). Animal electrophysiological studies demonstrate 
direct evidence of the afferent input from nociceptors to the cerebellum 
(VanGilder 1975; Garwicz et al. 1998; Moulton et al. 2010), e.g., A-delta fiber 
stimulation leads to activation in Purkinje cells in the anterior lobe of the 
cerebellum in cats (Ekerot et al. 1987). Furthermore, accumulating evidence 
from human reports demonstrates that the cerebellar processing may be more 
directly related to pain and nociceptive modulation (Bingel et al. 2002; Helmchen 
et al. 2003; Moulton et al. 2011). In support of this, noxious heat produced 
cerebellar activation even under general anesthesia using propofol (Hofbauer et 
al. 2004). By considering the current results, the noxious stimulation in phase 1 
led to cerebellar activation that was widely distributed in the posterior and 
anterior lobes. In contrast, the pINS seed region demonstrated an exclusive 
functional coupling with the cerebellar culmen in the anterior lobe during pain 
relief, suggesting a distinct nociceptive modulatory relationship between these 
two brain regions. Evidence supporting this observation comes from a rat study 
where microinjections of morphine into the cerebellar culmen resulted in acute 
analgesia (Dey and Ray 1982). Moreover, a recent study identified three 
functional cerebellar clusters during noxious stimulation, among which one 
significant cluster mainly involved the culmen that was functionally connected to 
the bilateral posterior portions of the insula (Diano et al. 2016). These results 
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indicate a potential role of the pINS and cerebellar culmen in basic nociceptive 
processing and modulation. 
 
Conclusion 
The neural block of trigeminal nociceptive primary afferents leads to a significant 
activity reduction in the pINS and OP1 regions, but not in other pain-associated 
brain areas. The current findings thus strengthen the evidence for the unique 
relevance of the operculo-insular cortex in pain perception. The pINS and OP1 
seed regions seem to maintain separate neural cross-talks that might be related 
to pain relief (cerebellar culmen) and immediate withdrawal behavior (pMCC). 
However, it must be noted that these conclusions are based on reverse 
inference. Thus, the likelihood of the reverse inference being true is a function of 
the degree to which the brain mechanism (e.g. pINS – cerebellum connectivity) is 
exclusively triggered by the proposed psychological state (pain relief). 
Nonetheless, the current results support the conceptual framework that during 
the pain experience, localized nociceptive nodes interact with distributed brain 
targets. 
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6 General Discussion and Conclusion  
Each study conducted within the frame of this doctoral thesis has its own specific 
discussion section, where the results are discussed, put into an appropriate 
scientific context and where the study limitations are thematized. The scope of 
this chapter is thus broader with an emphasis on the contributions of the 
presented studies for the answering of the main goal of this thesis.   
The overall aim of this work was to tackle methodical issues in 1H-MRS pain 
research in order to foster the establishment of this highly valuable method for 
answering some of the most urging topics in the field of human pain research.  
The first study conducted in this thesis (reproducibility study) addressed the 
common issue regarding anatomical and functional specificity. In this work, the 
typical approach usually applied in 1H-MRS studies was reversed: Instead of 
simply defining the measurement voxel dimensions necessary to achieve a 
certain SNR with the cost of high levels of interpretive ambiguity, our approach 
prioritized adequate regional and functional specificity and investigated possible 
resulting data quality limitations caused by this strategy. In my opinion, this may 
be the only accurate way to obtain meaningful information regarding certain 
processes-of-interest in small brain structures related to pain processing as such 
processes could otherwise be obscured by partial volume effects. Based on the 
evidence from pain research focusing on the specific roles of 
cytoarchitectonically and functionally distinct sub-compartments of the cingulate 
(pgACC and aMCC) and insular cortices, the rationale was to optimize voxel 
specificity optimally accounting for the boundaries of such highly specified 
substructures and to investigate the associated reproducibility of neurochemical 
quantification. The report showed that quantification in these pain-relevant 
subregions is feasible and reproducible using standard sequences and equipment 
in a modest amount of time. Although this work did not directly contribute to the 
field of pain neuroscience, it is nevertheless of importance due to various 
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reasons. First of all,  this work showed that neurochemical measurements with 
optimized anatomical and functional specificity is possible, hence potentially 
encouraging other groups to apply 1H-MRS to these substructures of the 
cingulate and insular cortices in various pain investigations. As an example, pain-
associated neurochemical patterns obtained from distinct small subregions of 
the cingulate and insular cortex might be compared to further corroborate their 
specific roles in pain processing. In addition, the combination of 1H-MRS and 
fMRI might foster a more thorough understanding of brain activity changes in 
these subregions, and in connectivity patterns between these subregions to 
other brain areas by providing complementary information about 
neurotransmitter systems. Secondly, this reproducibility work represents a solid 
foundation for the planning of future 1H-MRS pain studies in such areas by 
providing information about potential variance sources and expected variation 
levels, enabling the calculation of needed sample sizes for within- and between-
subjects designs. Thirdly, this work also pointed out the limitations of the applied 
standard 1H-MRS methods in dealing with signal disturbances. As an example, 
spectral resolution from the pgACC was 25% broader compared to the other 
regions probably due to pulsatile effects of the arteria cerebri anterior, resulting 
in reduced spectral linewidth due to B0-shifts. Thus, the application of a MC-
PRESS sequence to the pgACC might be highly beneficial due to the post-hoc 
correction of B0-shifts by frequency alignment of the water peaks.  
Nevertheless, it also shall be mentioned that new methods are emerging to 
further improve anatomical and functional specificity. New sequence types such 
as the “spatially selective excitation in two dimensions” (2D-SSE) enables the 
acquisition of highly specific 1H-MRS data by means of voxels with arbitrary 
shapes. This technique allows the free definition of measurement volume shapes 
for an optimal tracing of the contours of a region-of-interest (Waxmann et al., 
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2016). However, reproducibility examinations using this 2D-SSE technique to 
pain-relevant structures and their sub-compartments are still pending.  
The second study successfully addressed the issue regarding functional 1H-MRS 
investigations in the human brainstem. This is crucial as pointed out in the 
section 4.1 considering the multitude of animal studies linking neurochemical 
aberrations in brainstem structures to the etiology and maintenance of ongoing 
pain conditions (Sessle, 2000; Terayama et al., 2000; Porreca et al., 2002; Tracey 
and Mantyh, 2007; Graeff and Del-Ben, 2008; Ren and Dubner, 2011; Takeda et 
al., 2011; Denk et al., 2014; Samineni et al., 2017). As a first step in the closure of 
this scientific gap, this study investigated the feasibility of neurochemical 
quantification in the human TBSNC and the method’s sensitivity to detect 
induced neurochemical alterations in this brainstem structure. This study is 
important from various points of view. On the one hand, the applied MC-PRESS 
sequences successfully coped with brainstem-inherent signal disturbances, 
allowing the obtainment of highly reproducible data from a voxel with 2.4 cm3 
volume. Furthermore, this study suggests that neurochemical alterations are 
identifiable by detecting concentration decreases in tNAA and GABA in 
association with experimental orofacial pain stimulation. However, the pain-
specificity of the observed neurochemical dynamics in the TBSNC cannot be 
clearly answered with this study as only painful stimuli were applied for the 
induction of neurochemical changes. For this purpose, a replication of this 
experiment is planned with the addition of a non-painful condition in order to 
potentially differentiate nociceptive and somatosensory signal processing at 
brainstem level.  
As mentioned in the sections 3.1.4 and 4.1, this method could be very well suited 
for investigations in structures of the DPMS, including the PAG and RVM. This is 
of crucial importance regarding the eminent role of this brainstem allocated 
network in the regulation and modulation of nociceptive stimuli. Neurochemical 
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information obtained from the PAG and RVM may provide important cues about 
the differentiation of pro- and anti-nociceptive processes. In upcoming studies, 
we are going to apply the same procedure from the TBSNC-study to the human 
PAG and RVM. First tests are highly promising, showing high quality data from 
the PAG with a voxel size of only 1 cm3.  
The third study deviated from the focus on 1H-MRS by investigating pain-related 
processes in the brain using fMRI. Nevertheless, this study adds a valuable 
dimension to this doctoral thesis. This study applied a novel approach to identify 
and characterize regions showing discriminatory properties between non-painful 
from painful sensations. Instead of applying different stimuli intensities, the 
stimulus strength was kept constant, but the perceived intensity was modulated 
via the application of a nerve block using a lidocaine injection. Compared to the 
placebo condition, the lidocaine injection resulted in significant BOLD reductions 
in the posterior insula and parietal operculum, but not in other pain-related 
brain structures. These findings could hint to a unique relevance of the operculo-
insular cortex in coding of the transition from non-painful to painful experiences 
and vice versa.  
The replication of this study using 1H-MRS might provide additional valuable 
insights into the neural processes underlying the transition from painful to non-
painful sensations. In the first study (reproducibility study), the measurement 
characteristics in the posterior insula were already thoroughly investigated, 
providing a solid foundation for a replication of this study using 1H-MRS. 
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